Caleres 10Q 2022 Q3 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)



☒	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 29, 2022

☐	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _____________ to _____________

Commission file number: 1-2191


CALERES, INC.
(Exact name of registrant as specified in its charter)

New York	43-0197190
(State or other jurisdiction	(IRS Employer Identification Number)
of incorporation or organization)

8300 Maryland Avenue	63105
St. Louis, Missouri	(Zip Code)
(Address of principal executive offices)

(314) 854-4000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock - par value of $0.01 per share	CAL	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer ☑	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

As of November 25, 2022, 35,616,045 common shares were outstanding.

Table of Contents

PART IFINANCIAL INFORMATION

ITEM 1FINANCIAL STATEMENTS

CALERES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS



	(Unaudited)
($ thousands)	October 29, 2022		October 30, 2021		January 29, 2022
Assets
Current assets:
Cash and cash equivalents	$	32,773	$	74,772	$	30,115
Receivables, net		161,367		161,892		122,236
Inventories, net		649,257		543,218		596,807
Income taxes		12,046		35,026		33,073
Property and equipment, held for sale		16,777		—		5,455
Prepaid expenses and other current assets		48,864		47,790		48,790
Total current assets		921,084		862,698		836,476

Prepaid pension costs		106,781		96,705		99,139
Lease right-of-use assets		523,011		500,308		503,430
Property and equipment, net		151,798		155,516		150,238
Goodwill and intangible assets, net		218,420		230,625		227,503
Other assets		27,219		28,706		27,140
Total assets	$	1,948,313	$	1,874,558	$	1,843,926

Liabilities and Equity
Current liabilities:
Borrowings under revolving credit agreement	$	364,500	$	175,000	$	290,000
Current portion of long-term debt		—		99,598		—
Mandatory purchase obligation - Blowfish Malibu		—		54,558		—
Trade accounts payable		279,704		352,084		331,470
Income taxes		31,106		22,371		22,622
Lease obligations		133,227		128,151		128,495
Other accrued expenses		230,377		238,298		253,026
Total current liabilities		1,038,914		1,070,060		1,025,613

Other liabilities:
Noncurrent lease obligations		453,718		452,786		452,909
Income taxes		7,786		2,464		2,464
Deferred income taxes		15,044		13,603		14,731
Other liabilities		27,440		29,900		24,822
Total other liabilities		503,988		498,753		494,926

Equity:
Common stock		356		383		376
Additional paid-in capital		177,269		165,475		168,830
Accumulated other comprehensive loss		(7,187)		(8,471)		(8,606)
Retained earnings		228,006		143,711		157,970
Total Caleres, Inc. shareholders’ equity		398,444		301,098		318,570
Noncontrolling interests		6,967		4,647		4,817
Total equity		405,411		305,745		323,387
Total liabilities and equity	$	1,948,313	$	1,874,558	$	1,843,926

See notes to condensed consolidated financial statements.

Table of Contents

CALERES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS


	(Unaudited)
	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
($ thousands, except per share amounts)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Net sales	$	798,258	$	784,156	$	2,271,704	$	2,098,323
Cost of goods sold		458,382		448,805		1,268,019		1,165,792
Gross profit		339,876		335,351		1,003,685		932,531
Selling and administrative expenses		283,119		254,033		812,313		757,070
Restructuring and other special charges, net		2,910		—		2,910		13,482
Operating earnings		53,847		81,318		188,462		161,979
Interest expense, net		(4,003)		(5,069)		(8,886)		(28,803)
Loss on early extinguishment of debt		—		(649)		—		(649)
Other income, net		2,997		3,844		9,636		11,533
Earnings before income taxes		52,841		79,444		189,212		144,060
Income tax provision		(13,849)		(19,759)		(48,683)		(39,838)
Net earnings		38,992		59,685		140,529		104,222
Net (loss) earnings attributable to noncontrolling interests		(254)		63		(404)		1,057
Net earnings attributable to Caleres, Inc.	$	39,246	$	59,622	$	140,933	$	103,165

Basic earnings per common share attributable to Caleres, Inc. shareholders	$	1.09	$	1.56	$	3.83	$	2.70

Diluted earnings per common share attributable to Caleres, Inc. shareholders	$	1.08	$	1.54	$	3.79	$	2.68

See notes to condensed consolidated financial statements.

Table of Contents

CALERES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME


	(Unaudited)
	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Net earnings	$	38,992	$	59,685	$	140,529	$	104,222
Other comprehensive income (loss) ("OCI"), net of tax:
Foreign currency translation adjustment		(980)		(267)		(1,100)		(423)
Pension and other postretirement benefits adjustments		908		358		1,931		1,071
Other comprehensive (loss) income, net of tax		(72)		91		831		648
Comprehensive income		38,920		59,776		141,360		104,870
Comprehensive (loss) income attributable to noncontrolling interests		(419)		53		(992)		1,040
Comprehensive income attributable to Caleres, Inc.	$	39,339	$	59,723	$	142,352	$	103,830

��

See notes to condensed consolidated financial statements.

Table of Contents

CALERES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


	(Unaudited)
	Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021
Operating Activities
Net earnings	$	140,529	$	104,222
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation		23,945		25,617
Amortization of capitalized software		3,669		4,417
Amortization of intangible assets		9,080		9,446
Amortization of debt issuance costs and debt discount		305		732
Fair value adjustments to Blowfish mandatory purchase obligation		—		15,424
Loss on early extinguishment of debt		—		649
Share-based compensation expense		13,249		8,811
Loss on disposal of property and equipment		1,167		640
Impairment charges for property, equipment, and lease right-of-use assets		1,979		3,399
Adjustment to expected credit losses		(303)		(2,711)
Deferred income taxes		313		5,359
Changes in operating assets and liabilities:
Receivables		(38,826)		(32,188)
Inventories		(53,025)		(54,917)
Prepaid expenses and other current and noncurrent assets		(4,496)		(9,056)
Trade accounts payable		(51,547)		71,468
Accrued expenses and other liabilities		(33,667)		25,972
Income taxes, net		34,833		13,627
Other, net		(939)		(1,183)
Net cash provided by operating activities		46,266		189,728

Investing Activities
Purchases of property and equipment		(40,056)		(10,437)
Capitalized software		(5,350)		(4,122)
Net cash used for investing activities		(45,406)		(14,559)

Financing Activities
Borrowings under revolving credit agreement		708,500		363,000
Repayments under revolving credit agreement		(634,000)		(438,000)
Redemption of senior notes		—		(100,000)
Dividends paid		(7,698)		(8,011)
Debt issuance costs		—		(1,190)
Acquisition of treasury stock		(63,225)		—
Issuance of common stock under share-based plans, net		(4,804)		(3,779)
Contributions by noncontrolling interests		3,142		—
Other		—		(676)
Net cash provided by (used for) financing activities		1,915		(188,656)
Effect of exchange rate changes on cash and cash equivalents		(117)		(36)
Increase (decrease) in cash and cash equivalents		2,658		(13,523)
Cash and cash equivalents at beginning of period		30,115		88,295
Cash and cash equivalents at end of period	$	32,773	$	74,772

See notes to condensed consolidated financial statements.

Table of Contents

CALERES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY


						Accumulated				Total
						Other				Caleres, Inc.		Non-
(Unaudited)	Common Stock			Additional		Comprehensive		Retained		Shareholders’		controlling
($ thousands, except number of shares and per share amounts)	Shares	Dollars		Paid-In Capital		Loss		Earnings		Equity		Interests		Total Equity
BALANCE JULY 30, 2022	36,450,780	$	364	$	173,246	$	(7,280)	$	212,803	$	379,133	$	5,744	$	384,877
Net earnings									39,246		39,246		(254)		38,992
Foreign currency translation adjustment							(815)				(815)		(165)		(980)
Pension and other postretirement benefits adjustments, net of tax of $86							908				908				908
Comprehensive income (loss)							93		39,246		39,339		(419)		38,920
Contributions by noncontrolling interests											—		1,642		1,642
Dividends ($0.07 per share)									(2,498)		(2,498)				(2,498)
Acquisition of treasury stock	(838,025)		(8)						(21,545)		(21,553)				(21,553)
Issuance of common stock under share-based plans, net	20,699		0		(990)						(990)				(990)
Share-based compensation expense					5,013						5,013				5,013
BALANCE OCTOBER 29, 2022	35,633,454	$	356	$	177,269	$	(7,187)	$	228,006	$	398,444	$	6,967	$	405,411

BALANCE JULY 31, 2021	38,268,064	$	383	$	162,122	$	(8,572)	$	86,764	$	240,697	$	4,594	$	245,291
Net earnings									59,622		59,622		63		59,685
Foreign currency translation adjustment							(257)				(257)		(10)		(267)
Pension and other postretirement benefits adjustments, net of tax of $87							358				358				358
Comprehensive income							101		59,622		59,723		53		59,776
Dividends ($0.07 per share)									(2,675)		(2,675)				(2,675)
Issuance of common stock under share-based plans, net	(10,554)		(0)		(27)						(27)				(27)
Share-based compensation expense					3,380						3,380				3,380
BALANCE OCTOBER 30, 2021	38,257,510	$	383	$	165,475	$	(8,471)	$	143,711	$	301,098	$	4,647	$	305,745


						Accumulated
						Other				Total Caleres, Inc.		Non-
(Unaudited)	Common Stock			Additional		Comprehensive		Retained		Shareholders’		controlling
($ thousands, except number of shares and per share amounts)	Shares	Dollars		Paid-In Capital		Loss		Earnings		Equity		Interests		Total Equity
BALANCE JANUARY 29, 2022	37,635,145	$	376	$	168,830	$	(8,606)	$	157,970	$	318,570	$	4,817	$	323,387
Net earnings (loss)									140,933		140,933		(404)		140,529
Foreign currency translation adjustment							(512)				(512)		(588)		(1,100)
Pension and other postretirement benefits adjustments, net of tax of $417							1,931				1,931		—		1,931
Comprehensive income (loss)							1,419		140,933		142,352		(992)		141,360
Contributions by noncontrolling interests											—		3,142		3,142
Dividends ($0.21 per share)									(7,698)		(7,698)				(7,698)
Acquisition of treasury stock	(2,622,845)		(26)						(63,199)		(63,225)				(63,225)
Issuance of common stock under share-based plans, net	621,154		6		(4,810)						(4,804)				(4,804)
Share-based compensation expense					13,249						13,249				13,249
BALANCE OCTOBER 29, 2022	35,633,454	$	356	$	177,269	$	(7,187)	$	228,006	$	398,444	$	6,967	$	405,411

BALANCE JANUARY 30, 2021	37,966,204	$	380	$	160,446	$	(9,136)	$	48,557	$	200,247	$	3,607	$	203,854
Net earnings									103,165		103,165		1,057		104,222
Foreign currency translation adjustment							(406)				(406)		(17)		(423)
Pension and other postretirement benefits adjustments, net of tax of $269							1,071				1,071				1,071
Comprehensive income							665		103,165		103,830		1,040		104,870
Dividends ($0.21 per share)									(8,011)		(8,011)				(8,011)
Issuance of common stock under share-based plans, net	291,306		3		(3,782)						(3,779)				(3,779)
Share-based compensation expense					8,811						8,811				8,811
BALANCE OCTOBER 30, 2021	38,257,510	$	383	$	165,475	$	(8,471)	$	143,711	$	301,098	$	4,647	$	305,745

See notes to condensed consolidated financial statements.

Table of Contents

CALERES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 Basis of Presentation and General

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q of the United States Securities and Exchange Commission (“SEC”) and reflect all adjustments and accruals of a normal recurring nature, which management believes are necessary to present fairly the financial position, results of operations, comprehensive income and cash flows of Caleres, Inc. ("the Company"). These statements, however, do not include all information and footnotes necessary for a complete presentation of the Company’s consolidated financial position, results of operations, comprehensive income and cash flows in conformity with accounting principles generally accepted in the United States. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries, after the elimination of intercompany accounts and transactions.

The Company’s business is seasonal in nature due to consumer spending patterns, with higher back-to-school and holiday season sales. Although the third fiscal quarter has historically accounted for a substantial portion of the Company’s earnings for the year, the Company is beginning to experience more equal distribution among the quarters. Interim results may not necessarily be indicative of results which may be expected for any other interim period or for the year as a whole.

Certain prior period amounts in the notes to the condensed consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications did not affect net earnings attributable to Caleres, Inc.

The accompanying condensed consolidated financial statements and footnotes should be read in conjunction with the consolidated financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the year ended January 29, 2022.

Noncontrolling Interests

During 2019, the Company entered into a joint venture with Brand Investment Holding Limited (“Brand Investment Holding”), a member of the Gemkell Group, to sell Sam Edelman, Naturalizer and other branded footwear in China. The Company and Brand Investment Holding are each 50% owners of the joint venture, which is named CLT Brand Solutions (“CLT”). During the thirty-nine weeks ended October 29, 2022, capital contributions of $6.3 million were made to CLT, including $3.1 million received from Brand Investment Holding. Net sales were $5.4 million and $13.2 million for the thirteen and thirty-nine weeks ended October 29, 2022, respectively. Operating losses were $0.3 million and $0.6 million for the thirteen and thirty-nine weeks ended October 29, 2022, respectively. Net sales and operating earnings were $4.7 million and $0.2 million, respectively, for the thirteen weeks and $14.5 million and $2.4 million, respectively, for the thirty-nine weeks ended October 30, 2021.

The Company had a joint venture agreement with a subsidiary of C. banner International Holdings Limited (“CBI”) to market Naturalizer footwear in China. The Company was a 51% owner of the joint venture (“B&H Footwear”), with CBI owning the other 49%. The license enabling the joint venture to market the footwear expired in August 2017 and the parties are in the process of dissolving their joint venture agreements.

The Company consolidates CLT and B&H Footwear into its condensed consolidated financial statements. Net earnings (loss) attributable to noncontrolling interests represents the share of net earnings or losses that is attributable to Brand Investment Holding and CBI. Transactions between the Company and the joint ventures have been eliminated in the condensed consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

CARES Act

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security ("CARES") Act was enacted. The CARES Act includes a provision that allowed the Company to defer the employer portion of social security payroll tax payments that would have been paid between the enactment date and December 31, 2020, with 50% payable by December 31, 2021 and 50% payable by December 31, 2022. During 2020, the Company deferred approximately $9.4 million of employer social security payroll taxes. As of October 29, 2022, employer social security payroll taxes totaling $5.0 million, which are payable by December 31, 2022, are presented in other accrued expenses on the

Table of Contents

condensed consolidated balance sheet. As of October 30, 2021, approximately $4.7 million of deferred employer social security payroll taxes are recorded in other accrued expenses and $4.7 million was recorded in other liabilities on the condensed consolidated balance sheet.

Property and Equipment, Held for Sale

The Company is actively marketing to sell its nine-acre corporate headquarters campus (the “Campus”) located in Clayton, Missouri. The Company expects the Campus to qualify as a completed sale within the next year. Accordingly, the Campus has been classified as property and equipment, held for sale on the condensed consolidated balance sheet as of October 29, 2022 and is reflected within the Eliminations and Other category. The Company evaluated the Campus asset group for impairment indicators and determined that no indicators were present as of October 29, 2022.

Note 2 Impact of New Accounting Pronouncements

Impact of Prospective Accounting Pronouncements

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-04, Liabilities – Supplier Finance Programs (Topic 405-50): Disclosure of Supplier Finance Program Obligations. The guidance requires qualitative and quantitative disclosures about supplier finance programs in annual financial statements, including key terms of the programs, amounts outstanding, balance sheet presentation and a rollforward of amounts outstanding during the year. For interim periods, the ASU requires disclosure of total obligations outstanding that have been confirmed as valid. The ASU is effective for years beginning after December 15, 2022, except for the rollforward requirement, which is effective in fiscal year 2024. Early adoption is permitted. The amendments in the ASU will be applied retrospectively, except for the annual rollforward requirement, which will be applied prospectively. The adoption of the ASU is not expected to have a material impact on the Company’s financial statement disclosures.

Table of Contents

Note 3 Revenues

Disaggregation of Revenues

The following table disaggregates revenue by segment and major source for the periods ended October 29, 2022 and October 30, 2021:

Thirteen Weeks Ended October 29, 2022

Eliminations and

($ thousands)

Famous Footwear

Brand Portfolio

Other

Total

Retail stores

415,678

14,810

—

430,488

E-commerce - Company websites ⁽¹⁾

65,549

53,673

—

119,222

E-commerce - wholesale drop-ship ⁽¹⁾

—

40,672

(1,854)

38,818

Total direct-to-consumer sales

481,227

109,155

(1,854)

588,528

Wholesale - e-commerce ⁽¹⁾

—

59,035

—

59,035

Wholesale - landed

—

135,161

(5,081)

130,080

Wholesale - first cost

—

16,424

—

16,424

Licensing and royalty

601

3,454

—

4,055

Other ⁽²⁾

123

—

136

Net sales

481,951

323,242

(6,935)

798,258


	Thirteen Weeks Ended October 30, 2021
					Eliminations and
($ thousands)	Famous Footwear		Brand Portfolio		Other		Total

Retail stores	$	429,914	$	17,230	$	—	$	447,144
E-commerce -Company websites ⁽¹⁾		63,964		44,101		—		108,065
E-commerce - wholesale drop-ship ⁽¹⁾		—		22,054		(644)		21,410
Total direct-to-consumer sales		493,878		83,385		(644)		576,619
Wholesale - e-commerce ⁽¹⁾		—		47,409		—		47,409
Wholesale - landed		—		138,813		(10,373)		128,440
Wholesale - first cost		—		27,315		—		27,315
Licensing and royalty		602		3,536		—		4,138
Other ⁽²⁾		180		55		—		235
Net sales	$	494,660	$	300,513	$	(11,017)	$	784,156

Thirty-Nine Weeks Ended October 29, 2022

Eliminations and

($ thousands)

Famous Footwear

Brand Portfolio

Other

Total

Retail stores

1,133,276

43,371

—

1,176,647

E-commerce - Company websites ⁽¹⁾

167,604

155,698

—

323,302

E-commerce - wholesale drop-ship ⁽¹⁾

—

106,348

(3,759)

102,589

Total direct-to-consumer sales

1,300,880

305,417

(3,759)

1,602,538

Wholesale - e-commerce ⁽¹⁾

—

167,494

—

167,494

Wholesale - landed

—

441,544

(40,408)

401,136

Wholesale - first cost

—

88,205

—

88,205

Licensing and royalty

1,538

10,329

—

11,867

Other ⁽²⁾

410

—

464

Net sales

1,302,828

1,013,043

(44,167)

2,271,704

Table of Contents


	Thirty-Nine Weeks Ended October 30, 2021
					Eliminations and
($ thousands)	Famous Footwear		Brand Portfolio		Other		Total

Retail stores	$	1,166,837	$	44,241	$	—	$	1,211,078
E-commerce - Company websites ⁽¹⁾		178,367		136,458		—		314,825
E-commerce - wholesale drop-ship ⁽¹⁾		—		62,529		(1,477)		61,052
Total direct-to-consumer sales	$	1,345,204	$	243,228	$	(1,477)	$	1,586,955
Wholesale - e-commerce ⁽¹⁾		—		116,948		—		116,948
Wholesale - landed		—		353,597		(36,445)		317,152
Wholesale - first cost		—		67,651		—		67,651
Licensing and royalty		602		8,302		—		8,904
Other ⁽²⁾		607		106		—		713
Net sales	$	1,346,413	$	789,832	$	(37,922)	$	2,098,323

(1)	Collectively referred to as "e-commerce" in the narrative below

(2)	Includes breakage revenue from unredeemed gift cards

Retail stores

Traditionally, the majority of the Company’s revenue is generated from retail sales where control is transferred and revenue is recognized at the point of sale. Retail sales are recorded net of estimated returns and exclude sales tax. The Company records a returns reserve and a corresponding return asset for expected returns of merchandise.

Retail sales to members of the Company’s loyalty programs, including the Famously You Rewards program, include two performance obligations: the sale of merchandise and the delivery of points that may be redeemed for future purchases. The transaction price is allocated to the separate performance obligations based on the relative stand-alone selling price. The stand-alone selling price for the points is estimated using the retail value of the merchandise earned, adjusted for estimated breakage based upon historical redemption patterns. The revenue associated with the initial merchandise purchased is recognized immediately and the value assigned to the points is deferred until the points are redeemed, forfeited or expired.

E-commerce

The Company generates revenue from sales on websites maintained by the Company that are shipped from the Company’s distribution centers or retail stores directly to the consumer, or picked up directly by the consumer from the Company’s stores (“e-commerce – Company websites”); sales from the Company’s wholesale customers’ websites that are fulfilled on a drop-ship basis (“e-commerce – wholesale drop ship”); and other e-commerce sales (“wholesale – e-commerce”), collectively referred to as "e-commerce". The Company transfers control and recognizes revenue for merchandise sold that is shipped directly to an individual consumer upon delivery to the consumer.

Landed wholesale

Landed sales are wholesale sales in which the merchandise is shipped directly to the customer from the Company’s warehouses. Many customers purchasing footwear on a landed basis arrange their own transportation of merchandise and, with limited exceptions, control is transferred at the time of shipment.

First-cost wholesale

First-cost sales are wholesale sales in which the Company purchases merchandise from an international factory that manufactures the product and subsequently sells to a customer at an overseas port. Revenue is recognized at the time the merchandise is delivered to the customer’s designated freight forwarder and control is transferred to the customer.

Licensing and royalty

The Company has license agreements with third parties allowing them to sell the Company’s branded product, or other merchandise that uses the Company’s owned or licensed brand names. These license agreements provide the licensee access to the Company’s symbolic intellectual property, and revenue is therefore recognized over the license term. For royalty contracts that do not have guaranteed minimums, the Company recognizes revenue as the licensee’s sales occur. For royalty contracts that have guaranteed minimums, revenue for the guaranteed minimum is recognized on a straight-line basis during the term, until such time that the cumulative royalties exceed the total minimum guarantee. Up-front payments are recognized over the contractual term to which the guaranteed minimum relates.

Table of Contents

The Company also licenses its Famous Footwear trade name and logo to a third-party financial institution to offer Famous Footwear-branded credit cards to its consumers. The Company receives royalties based upon cardholder spending, which is recognized as licensing revenue at the time when the credit card is used.

Contract Balances

Revenue is recorded at the transaction price, net of estimates for variable consideration for which reserves are established, including returns, allowances and discounts. Variable consideration is estimated using the expected value method and given the large number of contracts with similar characteristics, the portfolio approach is applied to determine the variable consideration for each revenue stream. Reserves for projected returns are based on historical patterns and current expectations.

Information about significant contract balances from contracts with customers is as follows:


($ thousands)	October 29, 2022		October 30, 2021		January 29, 2022
Customer allowances and discounts	$	23,164	$	20,277	$	20,328
Loyalty programs liability		17,690		18,354		18,814
Returns reserve		16,619		15,704		12,468
Gift card liability		5,718		5,034		6,804

Changes in contract balances with customers generally reflect differences in relative sales volume for the periods presented. In addition, during the thirty-nine weeks ended October 29, 2022, the loyalty programs liability increased $32.5 million due to points and material rights earned on purchases and decreased $33.6 million due to expirations and redemptions. During the thirty-nine weeks ended October 30, 2021, the loyalty programs liability increased $27.4 million due to points and material rights earned on purchases and decreased $23.0 million due to expirations and redemptions. The liability for loyalty programs is presented within other accrued expenses when earned and is generally expected to be recognized as revenue within one year. The gift card liability is established upon the sale of a gift card and revenue is recognized either upon redemption of the gift card by the consumer or based upon the gift card breakage rate, which is generally within the 24-month period following the sale of the gift card.

The following table summarizes the activity in the Company’s allowance for expected credit losses during the thirty-nine weeks ended October 29, 2022 and October 30, 2021:


	Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021
Balance, beginning of period	$	9,601	$	14,928
Adjustment to expected credit losses		(303)		(2,711)
Uncollectible accounts written off, net of recoveries		(300)		(2,724)
Balance, end of period	$	8,998	$	9,493

Note 4 Earnings Per Share

The Company uses the two-class method to compute basic and diluted earnings per common share attributable to Caleres, Inc. shareholders. In periods of net loss, no effect is given to the Company’s participating securities since they do not contractually participate in the losses of

Table of Contents

the Company. The following table sets forth the computation of basic and diluted earnings per common share attributable to Caleres, Inc. shareholders for the periods ended October 29, 2022 and October 30, 2021:


	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
($ thousands, except per share amounts)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021

NUMERATOR
Net earnings	$	38,992	$	59,685	$	140,529	$	104,222
Net loss (earnings) attributable to noncontrolling interests		254		(63)		404		(1,057)
Net earnings attributable to Caleres, Inc.	$	39,246	$	59,622	$	140,933	$	103,165
Net earnings allocated to participating securities		(1,723)		(2,140)		(5,951)		(3,737)
Net earnings attributable to Caleres, Inc. after allocation of earnings to participating securities	$	37,523	$	57,482	$	134,982	$	99,428

DENOMINATOR
Denominator for basic earnings per common share attributable to Caleres, Inc. shareholders		34,379		36,889		35,207		36,825
Dilutive effect of share-based awards		507		457		450		294
Denominator for diluted earnings per common share attributable to Caleres, Inc. shareholders		34,886		37,346		35,657		37,119

Basic earnings per common share attributable to Caleres, Inc. shareholders	$	1.09	$	1.56	$	3.83	$	2.70

Diluted earnings per common share attributable to Caleres, Inc. shareholders	$	1.08	$	1.54	$	3.79	$	2.68

Options to purchase 16,667 shares of common stock for both the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were not included in the denominator for diluted earnings per common share attributable to Caleres, Inc. shareholders because the effect would be anti-dilutive.

During the thirteen and thirty-nine weeks ended October 29, 2022, the Company repurchased 838,025 and 2,622,845 shares, respectively, under the 2019 and 2022 publicly announced share repurchase programs, which permit repurchases of up to 5.0 million and 7.0 million shares, respectively. The Company did not repurchase any shares under the share repurchase programs during the thirty-nine weeks ended October 30, 2021. Refer to further discussion in Item 2, Unregistered Sales of Equity Securities and Use of Proceeds.

Note 5 Restructuring and Other Special Charges

Organizational Change

During the thirteen and thirty-nine weeks ended October 29, 2022, the Company incurred costs of $2.9 million ($2.7 million on an after-tax basis, or $0.07 per diluted share) related to a CFO transition at the corporate headquarters, with no corresponding charges for the thirty-nine weeks ended October 30, 2021. These costs were recognized as restructuring and other special charges in the condensed consolidated statement of earnings within the Eliminations and Other category.

Table of Contents

Blowfish Mandatory Purchase Obligation

In 2018, the Company acquired a controlling interest in Blowfish Malibu. The remaining interest was subject to a mandatory purchase obligation after a three-year period, which ended on July 31, 2021, based upon an earnings multiple formula as specified in the purchase agreement. Approximately $9.0 million was initially assigned to the mandatory purchase obligation and fair value adjustments were recorded as interest expense. The fair value adjustments on the mandatory purchase obligation totaled $1.9 million ($1.4 million on an after-tax basis, or $0.04 per diluted share) and $15.4 million ($11.5 million on an after-tax basis, or $0.30 per diluted share) for the thirteen and thirty-nine weeks ended October 30, 2021, respectively. There were no corresponding charges during the thirty-nine weeks ended October 29, 2022. The mandatory purchase obligation was settled for $54.6 million on November 4, 2021. Refer to further discussion regarding the mandatory purchase obligation in Note 14 to the condensed consolidated financial statements.

Brand Portfolio – Business Exits

During the thirty-nine weeks ended October 30, 2021, the Company incurred costs of $13.5 million ($11.9 million on an after-tax basis, or $0.31 per diluted share) related to the strategic realignment of the Naturalizer retail store operations. These costs primarily represented lease termination and other store closure costs, including employee severance, for the 73 stores that were closed during the first quarter of 2021. These charges are presented in restructuring and special charges on the condensed consolidated statement of earnings within the Brand Portfolio segment for the thirty-nine weeks ended October 30, 2021. There were no corresponding charges during the thirty-nine weeks ended October 29, 2022. As of October 29, 2022 and October 30, 2021, reserves of $0.0 million and $2.5 million, respectively, were included on the condensed consolidated balance sheets.

Note 6 Business Segment Information

Following is a summary of certain key financial measures for the Company’s business segments for the periods ended October 29, 2022 and October 30, 2021:


	Famous		Brand		Eliminations
($ thousands)	Footwear		Portfolio		and Other		Total
Thirteen Weeks Ended October 29, 2022
Net sales	$	481,951	$	323,242	$	(6,935)	$	798,258
Intersegment sales ⁽¹⁾		—		6,935		—		6,935
Operating earnings (loss)		59,267		22,304		(27,724)		53,847
Segment assets		833,268		955,712		159,333		1,948,313

Thirteen Weeks Ended October 30, 2021
Net sales	$	494,660	$	300,513	$	(11,017)	$	784,156
Intersegment sales⁽¹⁾		—		11,017		—		11,017
Operating earnings (loss)		87,375		11,383		(17,440)		81,318
Segment assets		736,858		909,175		228,525		1,874,558

Thirty-Nine Weeks Ended October 29, 2022
Net sales	$	1,302,828	$	1,013,043	$	(44,167)	$	2,271,704
Intersegment sales ⁽¹⁾		—		44,167		—		44,167
Operating earnings (loss)		171,451		93,063		(76,052)		188,462

Thirty-Nine Weeks Ended October 30, 2021
Net sales	$	1,346,413	$	789,832	$	(37,922)	$	2,098,323
Intersegment sales ⁽¹⁾		—		37,922		—		37,922
Operating earnings (loss)		220,746		25,116		(83,883)		161,979

(1)	Included in net sales in the Brand Portfolio segment and eliminated in the Eliminations and Other category.

The Eliminations and Other category includes corporate assets, administrative expenses and other costs and recoveries, which are not allocated to the operating segments, as well as the elimination of intersegment sales and profit.

Table of Contents

Following is a reconciliation of operating earnings to earnings before income taxes:


	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Operating earnings	$	53,847	$	81,318	$	188,462	$	161,979
Interest expense, net		(4,003)		(5,069)		(8,886)		(28,803)
Loss on early extinguishment of debt		—		(649)		—		(649)
Other income, net		2,997		3,844		9,636		11,533
Earnings before income taxes	$	52,841	$	79,444	$	189,212	$	144,060

Note 7 Inventories

The Company’s net inventory balance was comprised of the following:


($ thousands)	October 29, 2022		October 30, 2021		January 29, 2022
Raw materials	$	21,044	$	14,951	$	16,764
Work-in-process		629		581		614
Finished goods		627,584		527,686		579,429
Inventories, net	$	649,257	$	543,218	$	596,807

Note 8 Goodwill and Intangible Assets

Goodwill and intangible assets were as follows:


($ thousands)	October 29, 2022		October 30, 2021		January 29, 2022
Intangible Assets
Famous Footwear	$	2,800	$	2,800	$	2,800
Brand Portfolio		342,083		342,083		342,083
Total intangible assets		344,883		344,883		344,883
Accumulated amortization		(131,419)		(119,214)		(122,336)
Total intangible assets, net		213,464		225,669		222,547
Goodwill
Brand Portfolio ⁽¹⁾		4,956		4,956		4,956
Total goodwill		4,956		4,956		4,956
Goodwill and intangible assets, net	$	218,420	$	230,625	$	227,503

(1)	The carrying amount of goodwill as of October 29, 2022, October 30, 2021 and January 29, 2022 is presented net of accumulated impairment charges of $415.7 million.

Table of Contents

The Company’s intangible assets as of October 29, 2022, October 30, 2021 and January 29, 2022 were as follows:


($ thousands)	October 29, 2022
	Estimated Useful Lives			Accumulated		Accumulated
	(In Years)	Cost Basis		Amortization		Impairment		Net Carrying Value
Trade names	2 - 40	$	299,488	$	119,461	$	10,200	$	169,827
Trade names	Indefinite		107,400		—		92,000		15,400
Customer relationships	15 - 16		44,200		11,958		4,005		28,237
		$	451,088	$	131,419	$	106,205	$	213,464

	October 30, 2021
	Estimated Useful Lives			Accumulated		Accumulated
	(In Years)	Cost Basis		Amortization		Impairment		Net Carrying Value
Trade names	2 - 40	$	299,488	$	109,545	$	10,200	$	179,743
Trade names	Indefinite		107,400		—		92,000		15,400
Customer relationships	15 - 16		44,200		9,669		4,005		30,526
		$	451,088	$	119,214	$	106,205	$	225,669

	January 29, 2022
	Estimated Useful Lives			Accumulated		Accumulated
	(In Years)	Cost Basis		Amortization		Impairment		Net Carrying Value
Trade names	2 - 40	$	299,488	$	112,061	$	10,200	$	177,227
Trade names	Indefinite		107,400		—		92,000		15,400
Customer relationships	15 - 16		44,200		10,275		4,005		29,920
		$	451,088	$	122,336	$	106,205	$	222,547

Amortization expense related to intangible assets was $3.0 million and $3.1 million for the thirteen weeks ended October 29, 2022 and October 30, 2021, respectively, and $9.1 million and $9.4 million for the thirty-nine weeks ended October 29, 2022 and October 30, 2021, respectively. The Company estimates that amortization expense related to intangible assets will be approximately $12.1 million in 2022, $11.9 million in 2023 and $11.0 million in each of the fiscal years 2024, 2025 and 2026.

Goodwill is tested for impairment at least annually, or more frequently if events or circumstances indicate it might be impaired, using either the qualitative assessment or a quantitative fair value-based test. The Company recorded no goodwill impairment charges during the thirty-nine weeks ended October 29, 2022 or October 30, 2021.

Indefinite-lived intangible assets are tested for impairment as of the first day of the fourth quarter of each fiscal year unless events or circumstances indicate an interim test is required. The Company recorded no impairment charges for indefinite-lived intangible assets during the thirty-nine weeks ended October 29, 2022 or October 30, 2021.

Note 9 Leases

The Company leases all of its retail locations, a manufacturing facility, and certain office locations, distribution centers and equipment. At contract inception, leases are evaluated and classified as either operating or finance leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

Lease right-of-use assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The majority of the Company’s leases do not provide an implicit rate and therefore, the Company uses an incremental borrowing rate based on information available at the commencement date to determine the present value of future payments. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred.

The Company regularly analyzes the results of all of its stores and assesses the viability of underperforming stores to determine whether events or circumstances exist that indicate the stores should be closed or whether the carrying amount of their long-lived assets may not be recoverable. After allowing for an appropriate start-up period and consideration of any unusual nonrecurring events, property and equipment

Table of Contents

at stores and the lease right-of-use assets indicated as impaired are written down to fair value as calculated using a discounted cash flow method. The fair value of the lease right-of-use assets is determined utilizing projected cash flows for each store location, discounted using a risk-adjusted discount rate, subject to a market floor based on current market lease rates. The Company recorded no asset impairment charges in the thirteen weeks and asset impairment charges of $2.0 million for the thirty-nine weeks ended October 29, 2022. For the thirteen and thirty-nine weeks ended October 30, 2021, the Company recorded asset impairment charges of $1.1 million and $3.4 million, respectively. The impairment charges are primarily related to capitalized software and underperforming retail stores. Refer to Note 14 to the condensed consolidated financial statements for further discussion on these impairment charges.

As a result of the temporary store closures during the first half of 2020 associated with the pandemic, certain leases were amended to provide rent abatements and/or deferral of lease payments. Deferred payments continue to be reflected in lease obligations on the condensed consolidated balance sheets. Under relief provided by the FASB, entities could make a policy election to account for COVID-19-related lease concessions as if the enforceable rights existed under the original contract, accounting for them as variable rent rather than lease modifications. The Company made a policy election to account for rent abatements as variable rent. Accordingly, during the thirteen and thirty-nine weeks ended October 29, 2022, the Company recorded $0.4 million and $1.1 million, respectively, in lease concessions as a reduction of rent expense within selling and administrative expenses in the condensed consolidated statements of earnings. During the thirteen and thirty-nine-weeks October 30, 2021, the Company recorded $0.1 million and $1.7 million, respectively, in lease concessions. Rent concessions for leases that were extended were recognized as a lease modification.

During the thirty-nine weeks ended October 29, 2022, the Company entered into new or amended leases that resulted in the recognition of right-of-use assets and lease obligations of $130.7 million on the condensed consolidated balance sheets. As of October 29, 2022, the Company has entered into lease commitments for five retail locations for which the leases have not yet commenced. The Company anticipates that one lease will begin in the current fiscal year and four leases will begin in the next fiscal year. Upon commencement, right-of-use assets and lease liabilities of approximately $0.9 million will be recorded in the current fiscal year and $3.4 million will be recorded in the next fiscal year on the condensed consolidated balance sheets.

The components of lease expense for the thirteen and thirty-nine weeks ended October 29, 2022 and October 30, 2021 were as follows:


	Thirteen Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021
Operating lease expense	$	38,116	$	35,140
Variable lease expense		10,679		10,982
Short-term lease expense		970		737
Sublease income		—		(419)
Total lease expense	$	49,765	$	46,440


	Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021
Operating lease expense	$	109,810	$	112,838
Variable lease expense		29,567		30,985
Short-term lease expense		3,340		2,011
Sublease income		(59)		(477)
Total lease expense	$	142,658	$	145,357

Supplemental cash flow information related to leases is as follows:


	Thirty-Nine Weeks Ended
($ thousands)		October 29, 2022		October 30, 2021
Cash paid for lease liabilities⁽¹⁾		$	125,967	$	140,930
Cash received from sublease income			59		477

(1)

Cash paid for lease liabilities for the thirty-nine weeks ended October 29, 2022 includes payment of certain lease payments deferred in 2020, as described above, as well as lease termination costs associated with the Naturalizer retail store closings, as further discussed in Note 5 to the condensed consolidated financial statements.

Table of Contents

Note 10 Financing Arrangements

Credit Agreement

The Company maintains a revolving credit facility for working capital needs. The Company is the lead borrower, and Sidney Rich Associates, Inc., BG Retail, LLC, Allen Edmonds LLC, Vionic Group LLC and Vionic International LLC are each co-borrowers and guarantors. On April 8, 2022, Blowfish, LLC was joined to the Credit Agreement as a co-borrower and guarantor.

On October 5, 2021, the Company entered into a Fifth Amendment to Fourth Amended and Restated Credit Agreement (as so amended, the "Credit Agreement") which, among other modifications, decreased the amount available under the revolving credit facility by $100.0 million to an aggregate amount of up to $500.0 million, subject to borrowing base restrictions, and may be increased by up to $250.0 million. The Credit Agreement also decreased the spread applied to the London Interbank Offered Rate (“LIBOR”) or prime rate by a total of 75 basis points.

Borrowing availability under the Credit Agreement is limited to the lesser of the total commitments and the borrowing base ("Loan Cap"), which is based on stated percentages of the sum of eligible accounts receivable, eligible inventory and eligible credit card receivables, as defined, less applicable reserves. Under the Credit Agreement, the Loan Parties’ obligations are secured by a first-priority security interest in all accounts receivable, inventory and certain other collateral.

Interest on borrowings is at variable rates based on LIBOR (with a floor of 0.0%), or the prime rate (as defined in the Credit Agreement), plus a spread. The interest rate and fees for letters of credit vary based upon the level of excess availability under the Credit Agreement. There is an unused line fee payable on the unused portion under the facility and a letter of credit fee payable on the outstanding face amount under letters of credit.

The Credit Agreement limits the Company’s ability to create, incur, assume or permit to exist additional indebtedness and liens, make investments or specified payments, give guarantees, pay dividends, make capital expenditures and merge or acquire or sell assets. In addition, if excess availability falls below the greater of 10.0% of the Loan Cap and $40.0 million for three consecutive business days, and the fixed charge coverage ratio is less than 1.25 to 1.0, the Company would be in default under the Credit Agreement and certain additional covenants would be triggered.

The Credit Agreement contains customary events of default, including, without limitation, payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to similar obligations, certain events of bankruptcy and insolvency, judgment defaults and the failure of any guaranty or security document supporting the agreement to be in full force and effect. If an event of default occurs, the collateral agent may assume dominion and control over the Company’s cash (a “cash dominion event”) until such event of default is cured or waived or the excess availability exceeds such amount for 30 consecutive days, provided that a cash dominion event shall be deemed continuing (even if an event of default is no longer continuing and/or excess availability exceeds the required amount for 30 consecutive business days) after a cash dominion event has occurred and been discontinued on two occasions in any 12-month period. The Credit Agreement also contains certain other covenants and restrictions. The Company was in compliance with all covenants and restrictions under the Credit Agreement as of October 29, 2022.

At October 29, 2022, the Company had $364.5 million of borrowings outstanding and $10.1 million in letters of credit outstanding under the Credit Agreement. Total additional borrowing availability was $125.4 million at October 29, 2022.

Senior Notes

On July 27, 2015, the Company issued $200.0 million aggregate principal amount of senior notes due on August 15, 2023 (the "Senior Notes"). The Senior Notes bore interest at 6.25%, which was payable on February 15 and August 15 of each year. The Senior Notes were guaranteed on a senior unsecured basis by each of the Company’s subsidiaries that is a borrower or guarantor under the Credit Agreement. On August 16, 2021, the Company redeemed $100.0 million of Senior Notes at 100.0%. In addition, on January 3, 2022, the remaining $100.0 million of Senior Notes were redeemed at 100.0%, extinguishing the Company’s long-term debt.

Loss on Early Extinguishment of Debt

In conjunction with the early redemption of the Senior Notes in August 2021 and the amendment of the revolving credit facility in October 2021, the Company incurred losses totaling $0.6 million.

Table of Contents

Note 11 Shareholders’ Equity

Accumulated Other Comprehensive Loss

The following table sets forth the changes in accumulated other comprehensive loss (OCL) by component for the periods ended October 29, 2022 and October 30, 2021:



			Pension and		Accumulated
	Foreign		Other		Other
	Currency		Postretirement		Comprehensive
($ thousands)	Translation		Transactions ⁽¹⁾		(Loss) Income
Balance at July 30, 2022	$	(485)	$	(6,795)	$	(7,280)
Other comprehensive loss before reclassifications		(815)		—		(815)
Reclassifications:
Amounts reclassified from accumulated other comprehensive loss		—		994		994
Tax benefit		—		(86)		(86)
Net reclassifications		—		908		908
Other comprehensive (loss) income		(815)		908		93
Balance at October 29, 2022	$	(1,300)	$	(5,887)	$	(7,187)

Balance at July 31, 2021	$	(260)	$	(8,312)	$	(8,572)
Other comprehensive loss before reclassifications		(257)		—		(257)
Reclassifications:
Amounts reclassified from accumulated other comprehensive loss		—		445		445
Tax benefit		—		(87)		(87)
Net reclassifications		—		358		358
Other comprehensive (loss) income		(257)		358		101
Balance at October 30, 2021	$	(517)	$	(7,954)	$	(8,471)

Balance at January 29, 2022	$	(788)	$	(7,818)	$	(8,606)
Other comprehensive loss before reclassifications		(512)		—		(512)
Reclassifications:
Amounts reclassified from accumulated other comprehensive loss		—		2,348		2,348
Tax benefit		—		(417)		(417)
Net reclassifications		—		1,931		1,931
Other comprehensive (loss) income		(512)		1,931		1,419
Balance at October 29, 2022	$	(1,300)	$	(5,887)	$	(7,187)

Balance at January 30, 2021	$	(111)	$	(9,025)	$	(9,136)
Other comprehensive loss before reclassifications		(406)		—		(406)
Reclassifications:
Amounts reclassified from accumulated other comprehensive loss		—		1,340		1,340
Tax benefit		—		(269)		(269)
Net reclassifications		—		1,071		1,071
Other comprehensive (loss) income		(406)		1,071		665
Balance at October 30, 2021	$	(517)	$	(7,954)	$	(8,471)

(1)	Amounts reclassified are included in other income, net. Refer to Note 13 to the condensed consolidated financial statements for additional information related to pension and other postretirement benefits.

Note 12 Share-Based Compensation

The Company recognized share-based compensation expense of $5.0 million and $3.4 million during the thirteen weeks and $13.2 million and $8.8 million during the thirty-nine weeks ended October 29, 2022 and October 30, 2021, respectively.

Table of Contents

The Company had net issuances (repurchases) of 20,699 and (10,554) shares of common stock during the thirteen weeks ended October 29, 2022 and October 30, 2021, respectively, for restricted stock grants, stock performance awards issued to employees and common and restricted stock grants issued to non-employee directors, net of forfeitures and shares withheld to satisfy the tax withholding requirement. During the thirty-nine weeks ended October 29, 2022 and October 30, 2021, the Company had net issuances of 621,154 and 291,306 shares of common stock, respectively, related to share-based plans.

Restricted Stock

The following table summarizes restricted stock activity for the periods ended October 29, 2022 and October 30, 2021:

Thirteen Weeks Ended

Thirteen Weeks Ended

October 29, 2022

October 30, 2021

Weighted-

Weighted-

Total Number

Average

Total Number

Average

of Restricted

Grant Date

of Restricted

Grant Date

Shares

Fair Value

Fair Value

July 30, 2022

1,579,202

17.53

July 31, 2021

1,380,246

14.05

Granted

45,050

26.65

Granted

—

Forfeited

(15,500)

21.00

Forfeited

(9,500)

15.72

Vested

(58,000)

13.16

Vested

(3,500)

26.42

October 29, 2022

1,550,752

17.92

October 30, 2021

1,367,246

14.01

Thirty-Nine Weeks Ended

Thirty-Nine Weeks Ended

October 29, 2022

October 30, 2021

Weighted-

Weighted-

Total Number

Average

Total Number

Average

of Restricted

Grant Date

of Restricted

Grant Date

Shares

Fair Value

Fair Value

January 29, 2022

1,390,397

14.24

January 30, 2021

1,397,227

16.74

Granted

726,720

21.45

Granted

568,916

18.73

Forfeited

(95,716)

15.35

Forfeited

(78,375)

15.48

Vested

(470,649)

13.02

Vested

(520,522)

26.26

October 29, 2022

1,550,752

17.92

October 30, 2021

1,367,246

14.01

The Company granted 45,050 restricted shares during the thirteen weeks ended October 29, 2022, which have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years. Of the 726,720 restricted shares granted during the thirty-nine weeks ended October 29, 2022, 716,250 restricted shares have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years, and 10,470 shares have a cliff-vesting term of one year. There were no restricted shares granted during the thirteen weeks ended October 30, 2021. Of the 568,916 restricted shares granted during the thirty-nine weeks October 30 2021, 544,006 shares have a graded-vesting term of three years, with 50% vesting after two years and 50% after three years, 20,000 shares have a cliff-vesting term of two years and 4,910 shares have a cliff-vesting term of one year.

Performance Awards

During the thirty-nine weeks ended October 29, 2022, the Company granted performance share awards for a targeted 87,750 shares, with a weighted-average grant date fair value of $20.99 in connection with the 2020 performance award. During the thirty-nine weeks ended October 30, 2021, the Company granted performance share awards for a targeted 175,500 shares, with a weighted-average grant date fair value of $18.63. There were no performance-based share awards granted by the Company during the thirteen weeks ended October 29, 2022 or October 30, 2021. Vesting of performance-based awards is generally dependent upon the financial performance of the Company and the attainment of certain financial goals during the three-year period following the grant. At the end of the vesting period, the employee will have earned an amount of shares or units between 0% and 200% of the targeted award, depending on the achievement of the specified financial goals for the service period. Compensation expense is recognized based on the fair value of the award and the anticipated number of shares or units to be awarded for each tranche in accordance with the vesting schedule of the units over the three-year service period.

In connection with the Company’s CFO transition during the thirteen weeks ended October 29, 2022, the Company approved the accelerated vesting of 30,000 performance-based share awards, representing two of the four award tranches from the 2020 performance award. The

Table of Contents

performance conditions had been satisfied for the two award tranches based on the achievement of financial goals for the 2020 and 2021 fiscal periods. The modification to accelerate vesting eliminated the remaining service requirement. These awards had a weighted-average grant date fair value of $13.05 per share, but were revalued using a fair value on the date of modification of $24.31 per share. The modification of these awards resulted in incremental compensation expense of $0.4 million, which is presented in restructuring and other special charges on the condensed consolidated statements of earnings for the thirteen and thirty-nine weeks ended October 29, 2022.

During the thirty-nine weeks ended October 29, 2022, the Company granted long-term incentive awards payable in cash for the 2022-2024 performance period, with a target value of $8.3 million and a maximum value of $16.6 million. During the thirty-nine weeks ended October 30, 2021, the Company granted long-term incentive awards payable in cash for the 2021-2023 performance period, with a target value of $6.5 million and a maximum value of $13.0 million. These awards, which vest after a three-year period, are dependent upon the attainment of certain financial goals of the Company for each of the three years and individual achievement of strategic initiatives over the cumulative period of the award. The estimated values of the awards, which are reflected within other liabilities on the condensed consolidated balance sheets, are being expensed ratably over the three-year performance period. There were no performance-based awards payable in cash granted by the Company during the thirteen weeks ended October 29, 2022 or October 30, 2021.

Restricted Stock Units for Non-Employee Directors

Equity-based grants may be made to non-employee directors in the form of restricted stock units ("RSUs") payable in cash or common stock at no cost to the non-employee director. The RSUs are subject to a vesting requirement (usually one year) and earn dividend equivalents at the same rate as dividends on the Company’s common stock. The dividend equivalents, which vest immediately, are automatically re-invested in additional RSUs. Expense related to the initial grant of RSUs is recognized ratably over the vesting period based upon the fair value of the RSUs. The RSUs payable in cash are remeasured at the end of each period. Expense for the dividend equivalents is recognized at fair value when the dividend equivalents are granted. Gains and losses resulting from changes in the fair value of the RSUs payable in cash subsequent to the vesting period and through the settlement date are recognized in the Company’s condensed consolidated statements of earnings. The Company granted 1,314 and 1,739 RSUs to non-employee directors for dividend equivalents, during the thirteen weeks ended October 29, 2022 and October 30, 2021, respectively, with weighted-average grant date fair values of $24.30 and $22.49, respectively. The Company granted 41,325 and 44,180 RSUs to non-employee directors, including 4,680 and 4,900 for dividend equivalents, during the thirty-nine weeks ended October 29, 2022 and October 30, 2021, respectively, with weighted-average grant date fair values of $27.23 and $27.03, respectively.

Table of Contents

Note 13 Retirement and Other Benefit Plans

The following table sets forth the components of net periodic benefit income for the Company, including the domestic and Canadian plans:


	Pension Benefits				Other Postretirement Benefits
	Thirteen Weeks Ended				Thirteen Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Service cost	$	1,786	$	1,872	$	—	$	—
Interest cost		2,997		2,811		9		8
Expected return on assets		(6,997)		(7,108)		—		—
Amortization of:
Actuarial loss (gain)		779		601		(26)		(27)
Prior service income		(79)		(129)		—		—
Settlement cost		320		—		—		—
Total net periodic benefit income	$	(1,194)	$	(1,953)	$	(17)	$	(19)


	Pension Benefits				Other Postretirement Benefits
	Thirty-Nine Weeks Ended				Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Service cost	$	5,358	$	5,615	$	—	$	—
Interest cost		8,994		8,430		27		28
Expected return on assets		(21,005)		(21,331)		—		—
Amortization of:
Actuarial loss (gain)		2,343		1,808		(78)		(82)
Prior service income		(237)		(386)		—		—
Settlement cost		320		—		—		—
Total net periodic benefit income	$	(4,227)	$	(5,864)	$	(51)	$	(54)

The non-service cost components of net periodic benefit income are included in other income, net in the condensed consolidated statements of earnings. Service cost is included in selling and administrative expenses.

Note 14 Fair Value Measurements

Fair Value Hierarchy

Fair value measurement disclosure requirements specify a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (“observable inputs”) or reflect the Company’s own assumptions of market participant valuation (“unobservable inputs”). In accordance with the fair value guidance, the inputs to valuation techniques used to measure fair value are categorized into three levels based on the reliability of the inputs as follows:

●	Level 1 – Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

●	Level 2 – Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

●	Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

In determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company also considers counterparty credit risk in its assessment of fair value. Classification of the financial or non-financial asset or liability within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

Table of Contents

Measurement of Fair Value

The Company measures fair value as an exit price, the price to sell an asset or transfer a liability in an orderly transaction between market participants at the measurement date, using the procedures described below for all financial and non-financial assets and liabilities measured at fair value.

Money Market Funds

The Company periodically invests in cash equivalents consisting of short-term money market funds backed by U.S. Treasury securities to preserve the Company’s capital for the purpose of funding operations. It does not enter into money market funds for trading or speculative purposes. The fair value is based on unadjusted quoted market prices for the funds in active markets with sufficient volume and frequency (Level 1).

Non-Qualified Deferred Compensation Plan Assets and Liabilities

The Company maintains a non-qualified deferred compensation plan (the “Deferred Compensation Plan”) for the benefit of certain management employees. The investment funds offered to the participants generally correspond to the funds offered in the Company’s 401(k) plan, and the account balance fluctuates with the investment returns on those funds. The Deferred Compensation Plan permits the deferral of up to 50% of base salary and 100% of compensation received under the Company’s annual incentive plan. The deferrals are held in a separate trust, which has been established by the Company to administer the Deferred Compensation Plan. The assets of the trust are subject to the claims of the Company’s creditors in the event that the Company becomes insolvent. Consequently, the trust qualifies as a grantor trust for income tax purposes (i.e., a “Rabbi Trust”). The liabilities of the Deferred Compensation Plan are presented in other accrued expenses and the assets held by the trust are classified within prepaid expenses and other current assets in the condensed consolidated balance sheets. Changes in deferred compensation plan assets and liabilities are charged to selling and administrative expenses. The fair value is based on unadjusted quoted market prices for the funds in active markets with sufficient volume and frequency (Level 1).

Deferred Compensation Plan for Non-Employee Directors

Non-employee directors are eligible to participate in a deferred compensation plan with deferred amounts valued as if invested in the Company’s common stock through the use of phantom stock units (“PSUs”). Under the plan, each participating director’s account is credited with the number of PSUs equal to the number of shares of the Company’s common stock that the participant could purchase or receive with the amount of the deferred compensation, based upon the average of the high and low prices of the Company’s common stock on the last trading day of the fiscal quarter when the cash compensation was earned. Dividend equivalents are paid on PSUs at the same rate as dividends on the Company’s common stock and are re-invested in additional PSUs at the next fiscal quarter-end. The liabilities of the plan are based on the fair value of the outstanding PSUs and are presented in other accrued expenses (current portion) or other liabilities in the condensed consolidated balance sheets. Gains and losses resulting from changes in the fair value of the PSUs are presented in selling and administrative expenses in the Company’s condensed consolidated statements of earnings. The fair value of each PSU is based on an unadjusted quoted market price for the Company’s common stock in an active market with sufficient volume and frequency on each measurement date (Level 1).

Restricted Stock Units for Non-Employee Directors

Under the Company’s incentive compensation plans, cash-equivalent restricted stock units (“RSUs”) of the Company were previously granted at no cost to non-employee directors. These cash-equivalent RSUs are subject to a vesting requirement (usually one year), earn dividend-equivalent units, and are settled in cash on the date the director terminates service or such earlier date as a director may elect, subject to restrictions, based on the then current fair value of the Company’s common stock. The fair value of each cash-equivalent RSU is based on an unadjusted quoted market price for the Company’s common stock in an active market with sufficient volume and frequency on each measurement date (Level 1). Additional information related to RSUs for non-employee directors is disclosed in Note 12 to the condensed consolidated financial statements.

Mandatory Purchase Obligation

The Company recorded a mandatory purchase obligation of the remaining interest in conjunction with the acquisition of Blowfish Malibu in July 2018. The fair value of the mandatory purchase obligation was based on the earnings formula specified in the purchase agreement (Level 3). Fair value adjustments on the mandatory purchase obligation were recorded as interest expense. There were no fair value adjustments for the thirteen and thirty-nine weeks ended October 29, 2022. The Company recorded fair value adjustments of $1.9 million and $15.4 million for the thirteen and thirty-nine weeks ended October 30, 2021, respectively. The mandatory purchase obligation of $54.6 million was paid on November 4, 2021. Refer to further discussion of the mandatory purchase obligation in Note 5 to the condensed consolidated financial statements.

Table of Contents

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at October 29, 2022, October 30, 2021 and January 29, 2022. During the thirty-nine weeks ended October 29, 2022 and October 30, 2021, there were no transfers into or out of Level 3.


	Fair Value Measurements
($ thousands)	Total		Level 1		Level 2		Level 3
Asset (Liability)
October 29, 2022:
Non-qualified deferred compensation plan assets	$	7,769	$	7,769	$	—	$	—
Non-qualified deferred compensation plan liabilities		(7,769)		(7,769)		—		—
Deferred compensation plan liabilities for non-employee directors		(1,805)		(1,805)		—		—
Restricted stock units for non-employee directors		(2,220)		(2,220)		—		—
October 30, 2021:
Cash equivalents – money market funds	$	35,000	$	35,000	$	—	$	—
Non-qualified deferred compensation plan assets		7,789		7,789		—		—
Non-qualified deferred compensation plan liabilities		(7,789)		(7,789)		—		—
Deferred compensation plan liabilities for non-employee directors		(1,764)		(1,764)		—		—
Restricted stock units for non-employee directors		(2,558)		(2,558)		—		—
Mandatory purchase obligation - Blowfish Malibu		(54,558)		—		—		(54,558)
January 29, 2022:
Non-qualified deferred compensation plan assets		7,463		7,463		—		—
Non-qualified deferred compensation plan liabilities		(7,463)		(7,463)		—		—
Deferred compensation plan liabilities for non-employee directors		(1,770)		(1,770)		—		—
Restricted stock units for non-employee directors		(2,568)		(2,568)		—		—

Impairment Charges

The Company assesses the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company considers important that could trigger an impairment review include underperformance relative to historical or projected future operating results, a significant change in the manner of the use of the asset, or a negative industry or economic trend. When the Company determines that the carrying value of long-lived assets may not be recoverable based upon the existence of one or more of the aforementioned factors, impairment is measured based on a projected discounted cash flow method. Certain factors, such as estimated store sales and expenses, used for this nonrecurring fair value measurement are considered Level 3 inputs as defined by FASB ASC Topic 820, Fair Value Measurement. Long-lived assets held and used with a carrying amount of $564.6 million and $542.3 million at October 29, 2022 and October 30, 2021, respectively, were assessed for indicators of impairment. This assessment resulted in the following impairment charges, primarily for capitalized software and operating lease right-of-use assets, leasehold improvements and furniture and fixtures in the Company’s retail stores.


	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
($ thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Long-Lived Asset Impairment Charges
Famous Footwear	$	—	$	400	$	419	$	1,200
Brand Portfolio		—		711		1,560		2,199
Total long-lived asset impairment charges	$	—	$	1,111	$	1,979	$	3,399

Fair Value of the Company’s Other Financial Instruments

The fair values of cash and cash equivalents (excluding money market funds discussed above), receivables and trade accounts payable approximate their carrying values due to the short-term nature of these instruments.

Table of Contents

The carrying amounts and fair values of the Company’s other financial instruments subject to fair value disclosures are as follows:


	October 29, 2022				October 30, 2021				January 29, 2022
($ thousands)	Carrying Value ⁽¹⁾		Fair Value		Carrying Value ⁽¹⁾		Fair Value		Carrying Value ⁽¹⁾		Fair Value
Borrowings under revolving credit agreement	$	364,500	$	364,500	$	175,000	$	175,000	$	290,000	$	290,000
Current portion of long-term debt		—		—		100,000		100,000		—		—
Total debt	$	364,500	$	364,500	$	275,000	$	275,000	$	290,000	$	290,000

(1)	Excludes unamortized debt issuance costs and debt discount

The fair values of borrowings under revolving credit agreement and current portion of long-term debt approximate their carrying values due to the short-term nature of these borrowings (Level 1).

Note 15 Income Taxes

The Company’s consolidated effective tax rate can vary considerably from period to period, depending on a number of factors. The Company’s consolidated effective tax rates were 26.2% and 24.9% for the thirteen weeks ended October 29, 2022 and October 30, 2021, respectively. The higher effective tax rate for the thirteen weeks ended October 29, 2022 was driven by an increase in permanent adjustments, primarily due to the non-deductible portion of executive compensation.

The Company’s consolidated effective tax rate was 25.7% for the thirty-nine weeks ended October 29, 2022, compared to 27.7% for the nine months ended October 30, 2021. The higher effective tax rate for the thirty-nine weeks ended October 30, 2021 primarily reflects the incremental valuation allowances for the Company’s deferred tax assets for certain jurisdictions recorded in the thirty-nine weeks ended October 30, 2021, as well as the non-deductibility of losses at the Company’s Canadian division, which were driven by exit-related costs associated with Naturalizer retail stores in the first quarter of 2021.

As of October 29, 2022, no deferred taxes have been provided on the accumulated unremitted earnings of the Company’s foreign subsidiaries that are not subject to United States income tax, beyond the amounts recorded for the one-time transition tax for the mandatory deemed repatriation of cumulative foreign earnings, as required by the Tax Cuts and Jobs Act. The Company periodically evaluates its international investment opportunities and plans, as well as its international working capital needs, to determine the level of investment required and, accordingly, determines the level of international earnings that is considered indefinitely reinvested. Based upon that evaluation, earnings of the Company’s international subsidiaries that are not otherwise subject to United States taxation are considered to be indefinitely reinvested, and accordingly, deferred taxes have not been provided. If changes occur in future investment opportunities and plans, those changes will be reflected when known and may result in providing residual United States deferred taxes on unremitted international earnings.

Note 16 Commitments and Contingencies

Environmental Remediation

Prior operations included numerous manufacturing and other facilities for which the Company may have responsibility under various environmental laws for the remediation of conditions that may be identified in the future. The Company is involved in environmental remediation and ongoing compliance activities at several sites and has been notified that it is or may be a potentially responsible party at several other sites.

Redfield

The Company is remediating, under the oversight of Colorado authorities, the groundwater and indoor air at its owned facility in Colorado (the “Redfield site” or, when referring to remediation activities at or under the facility, the “on-site remediation”) and residential neighborhoods adjacent to and near the property (the “off-site remediation”) that have been affected by solvents previously used at the facility. The on-site remediation calls for the operation of a pump and treat system (which prevents migration of contaminated groundwater off the property) as the final remedy for the site, subject to monitoring and periodic review of the on-site conditions and other remedial technologies that may be developed in the future. In 2016, the Company submitted a revised plan to address on-site conditions, including direct treatment of source areas, and received approval from the oversight authorities to begin implementing the revised plan.

Table of Contents

As the treatment of the on-site source areas progresses, the Company expects to convert the pump and treat system to a passive treatment barrier system. Off-site groundwater concentrations have been reducing over time since installation of the pump and treat system in 2000 and injection of clean water beginning in 2003. However, localized areas of contaminated bedrock just beyond the property line continue to impact off-site groundwater. The modified work plan for addressing this condition includes converting the off-site bioremediation system into a monitoring well network and employing different remediation methods in these recalcitrant areas. In accordance with the work plan, a pilot test was conducted of certain groundwater remediation methods and the results of that test were used to develop more detailed plans for remedial activities in the off-site areas, which were approved by the authorities and are being implemented in a phased manner. The results of groundwater monitoring are being used to evaluate the effectiveness of these activities. The Company continues to implement the expanded remedy work plan that was approved by the oversight authorities in 2015. Based on the progress of the direct remedial action of on-site conditions, the Company submitted a request to the oversight authorities for permission to convert the perimeter pump and treat active remediation system to a passive one. In 2019, a final response was received from the oversight authorities, which is allowing the Company to proceed with implementation of the revised plan on a portion of the treatment system. The Company continues to pursue approval from the oversight authorities for the full conversion of the perimeter pump and treat active remediation system to a passive one. The Company also continues to work with the oversight authorities on the off-site work plan.

The cumulative expenditures for both on-site and off-site remediation through October 29, 2022 were $33.0 million. The Company has recovered a portion of these expenditures from insurers and other third parties. The reserve for the anticipated future remediation activities at October 29, 2022 is $9.7 million, of which $8.7 million is recorded within other liabilities and $1.0 million is recorded within other accrued expenses. Of the total $9.7 million reserve, $5.0 million is for off-site remediation and $4.7 million is for on-site remediation. The liability for the on-site remediation was discounted at 4.8%. On an undiscounted basis, the on-site remediation liability would be $13.4 million as of October 29, 2022. The Company expects to spend approximately $0.6 million in 2022, $0.1 million in each of the following four years and $12.4 million in the aggregate thereafter related to the on-site remediation.

Other

Various federal and state authorities have identified the Company as a potentially responsible party for remediation at certain other sites. However, the Company does not currently believe that its liability for such sites, if any, would be material.

The Company continues to evaluate its remediation plans in conjunction with its environmental consultants and records its best estimate of remediation liabilities. However, future actions and the associated costs are subject to oversight and approval of various governmental authorities. Accordingly, the ultimate costs may vary, and it is possible costs may exceed the recorded amounts.

Litigation

The Company is involved in legal proceedings and litigation arising in the ordinary course of business. In the opinion of management, the outcome of such ordinary course of business proceedings and litigation currently pending is not expected to have a material adverse effect on the Company’s results of operations or financial position. Legal costs associated with litigation are expensed as incurred.

Table of Contents

ITEM 2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

We delivered another period of strong financial and operational results for the third quarter, with record quarterly net sales and solid earnings. Our results underscore the strength and versatility of our portfolio of brands, highlight the significant progress we’ve made on our enterprise-wide strategic initiatives and demonstrate the portfolio’s enhanced resilience during periods of macroeconomic uncertainty. We are particularly pleased with the performance of our Brand Portfolio segment, which utilized our diverse portfolio of brands to meet the robust consumer demand and deliver year-over-year improvement in nearly all key financial metrics. During the third quarter of 2022, we also continued to execute on our capital return program and returned $24.1 million to shareholders through dividends and share repurchases.

Financial Highlights

Following is a summary of the financial highlights for the third quarter of 2022:

●

Consolidated net sales increased $14.1 million, or 1.8%, to $798.3 million in the third quarter of 2022, compared to $784.2 million in the third quarter of 2021. Our Famous Footwear segment continued its strong performance with net sales of $482.0 million. Net sales of our Brand Portfolio segment increased $22.7 million, or 7.6%, compared to the third quarter of 2021. On a consolidated basis, our direct-to-consumer sales represented approximately 74% of consolidated net sales for the third quarter of 2022, compared to 73% in the third quarter of 2021.

●

Consolidated gross profit increased $4.5 million, or 1.3%, to $339.9 million in the third quarter of 2022, compared to $335.4 million in the third quarter of 2021. Our gross profit margin decreased slightly to 42.6% in the third quarter of 2022, compared to 42.8% in the third quarter of 2021.

●

Consolidated operating earnings decreased $27.5 million to $53.8 million in the third quarter of 2022, compared to $81.3 million in the third quarter of 2021.

●

Consolidated net earnings attributable to Caleres, Inc. were $39.2 million, or $1.08 per diluted share, in the third quarter of 2022, compared to $59.6 million, or $1.54 per diluted share, in the third quarter of 2021.

The following items should be considered in evaluating the comparability of our third quarter results in 2022 and 2021:

●

Organizational changes – During the third quarter of 2022, we incurred costs of $2.9 million ($2.7 million on an after-tax basis, or $0.07 per diluted share) related to a CFO transition at our corporate headquarters, with no corresponding costs for the third quarter of 2021. Refer to Note 5 to the condensed consolidated financial statements for further discussion of these charges.

●

Blowfish Malibu mandatory purchase obligation – As further discussed in Note 5 and Note 14 to the condensed consolidated financial statements, the remaining interest in Blowfish Malibu was subject to a mandatory purchase obligation after a three-year period following the 2018 acquisition, based on an earnings multiple formula. During the third quarter of 2021, we recorded a fair value adjustment of $1.9 million ($1.4 million on an after-tax basis, or $0.04 per diluted share). The fair value adjustment was recorded as interest expense, net in the condensed consolidated statement of earnings. There were no corresponding charges in the third quarter of 2022. The purchase obligation was settled for $54.6 million on November 4, 2021.

Known Trends Impacting Our Business

Inflationary pressures, including higher product costs, higher parcel freight costs, wage inflation and the rising interest rate environment, continued to impact our financial results during the third quarter of 2022. The price increases we began implementing in the second half of 2021 have mitigated the majority of the inflationary pressures related to product costs. Macroeconomic factors, such as inflationary pressures and volatility in interest rates, also impact a number of accounting estimates, including impairment calculations, the value of inventory measured using the LIFO method, and other estimates that utilize fair value. These macroeconomic factors could result in incremental volatility in certain valuations and provisions required in the Company’s financial statements. In addition, ongoing general inflation and macroeconomic challenges continue to impact consumer sentiment and may result in lower consumer spending and a more promotional environment in the fourth quarter of 2022 and beyond.

Table of Contents

Metrics Used in the Evaluation of Our Business

The following are a couple of key metrics by which we evaluate our business and make strategic decisions:

Same-store sales

The same-store sales metric is a metric commonly used in the retail industry to evaluate the revenue generated for stores that have been open for more than a year, though other retailers may calculate the metric differently. Management uses the same-store sales metric as a measure of an individual store’s success to determine whether it is performing in line with expectations. Our same-store sales metric is a daily-weighted calculation for the period, which includes sales for stores that have been open for at least 13 months. In addition, in order to be included in the same-store sales metric, a store must be open in the current period as well as the corresponding day(s) of the comparable retail calendar in the prior year. Accordingly, closed stores are excluded from the same-store sales metric for each day of the closure. Relocated stores are treated as new stores and therefore excluded from the calculation. E-commerce sales for those websites that function as an extension of a retail chain are included in the same-store sales calculation. We believe the same-store sales metric is useful to shareholders and investors in assessing our retail sales performance of existing locations with comparable prior year sales, separate from the impact of store openings or store closures.

Sales per square foot

The sales per square foot metric is commonly used in the retail industry to calculate the efficiency of sales based upon the square footage in a store. Management uses the sales per square foot metric as a measure of an individual store’s success to determine whether it is performing in line with expectations. The sales per square foot metric is calculated by dividing total retail store sales, excluding e-commerce sales, by the total square footage of the retail store base at the end of each month of the respective period.

Outlook

We are sharply focused on the rapidly evolving market landscape and recognize that the uncertainty about the macro environment and the mounting threat of recessionary pressures could begin to dampen consumer spending habits. We have experienced a slower start to our holiday season sales trends, which may continue through the remainder of the fourth quarter of 2022. However, we believe our core competencies in brand building, product creation, marketing and logistics will enable us to navigate the challenging market environment. In addition, we believe we are well-positioned to capitalize on opportunities across a broad spectrum of consumer segments by leveraging our diverse portfolio of brands. In addition to maintaining our quarterly dividend, we plan to prioritize using available cash to reduce our revolver borrowings and increase overall liquidity.

Following are the consolidated results and the results by segment:

CONSOLIDATED RESULTS


	Thirteen Weeks Ended								Thirty-Nine Weeks Ended
	October 29, 2022				October 30, 2021				October 29, 2022				October 30, 2021
			% of				% of				% of				% of
($ millions)			Net Sales				Net Sales				Net Sales				Net Sales
Net sales	$	798.3	100.0	%	$	784.2	100.0	%	$	2,271.7	100.0	%	$	2,098.3	100.0	%
Cost of goods sold		458.4	57.4	%		448.8	57.2	%		1,268.0	55.8	%		1,165.8	55.6	%
Gross profit		339.9	42.6	%		335.4	42.8	%		1,003.7	44.2	%		932.5	44.4	%
Selling and administrative expenses		283.2	35.5	%		254.1	32.4	%		812.3	35.8	%		757.0	36.1	%
Restructuring and other special charges, net		2.9	0.4	%		—	—	%		2.9	0.1	%		13.5	0.6	%
Operating earnings		53.8	6.7	%		81.3	10.4	%		188.5	8.3	%		162.0	7.7	%
Interest expense, net		(4.0)	(0.5)	%		(5.1)	(0.7)	%		(8.9)	(0.4)	%		(28.8)	(1.4)	%
Loss on early extinguishment of debt		—	—	%		(0.6)	(0.1)	%		—	—	%		(0.6)	(0.0)	%
Other income, net		3.0	0.4	%		3.8	0.5	%		9.6	0.4	%		11.5	0.6	%
Earnings before income taxes		52.8	6.6	%		79.4	10.1	%		189.2	8.3	%		144.1	6.9	%
Income tax provision		(13.8)	(1.7)	%		(19.7)	(2.5)	%		(48.7)	(2.1)	%		(39.9)	(1.9)	%
Net earnings		39.0	4.9	%		59.7	7.6	%		140.5	6.2	%		104.2	5.0	%
Net (loss) earnings attributable to noncontrolling interests		(0.2)	(0.0)	%		0.1	0.0	%		(0.4)	(0.0)	%		1.0	0.1	%
Net earnings attributable to Caleres, Inc.	$	39.2	4.9	%	$	59.6	7.6	%	$	140.9	6.2	%	$	103.2	4.9	%

Net Sales

Net sales increased $14.1 million, or 1.8%, to $798.3 million for the third quarter of 2022, compared to $784.2 million for the third quarter of 2021. Net sales for our Brand Portfolio segment increased $22.7 million, or 7.6% during the third quarter of 2022, compared to the third quarter of 2021, led by strong performances by our Naturalizer, Sam Edelman, Franco Sarto and LifeStride brands. Net sales for our Famous Footwear segment remained strong, but decreased $12.7 million, or 2.6%, in the third quarter of 2022 compared to the record-setting third

Table of Contents

quarter of 2021, with same-store sales down 0.8%. On a consolidated basis, our direct-to-consumer sales represented approximately 74% of total net sales for the third quarter of 2022. We remain focused on maximizing the vertical opportunity between the Famous Footwear and Brand Portfolio segments, with LifeStride and Dr. Scholl’s representing two of Famous Footwear’s top 15 best-selling footwear brands during the quarter.

Net sales increased $173.4 million, or 8.3%, to $2,271.7 million for the nine months ended October 29, 2022, compared to $2,098.3 million for the nine months ended October 30, 2021. Net sales for our Brand Portfolio segment increased $223.2 million, or 28.3% during the first nine months of 2022, compared to the first nine months of 2021, driven by strong sales growth from nearly all of our brands. Our Famous Footwear segment’s sales momentum continued. However, net sales for Famous Footwear decreased $43.6 million, or 3.2%, in the first nine months of 2022 compared to the exceptionally strong first nine months of 2021, with same stores sales decreasing 2.5%. On a consolidated basis, our direct-to-consumer sales represented approximately 71% of total net sales for the nine months ended October 29, 2022.

Gross Profit

Gross profit increased $4.5 million, or 1.3%, to $339.9 million for the third quarter of 2022, compared to $335.4 million for the third quarter of 2021, reflecting higher net sales. As a percentage of net sales, gross profit decreased slightly to 42.6% for the third quarter of 2022, compared to 42.8% for the third quarter of 2021, reflecting a decrease in the gross profit margin of our Famous Footwear segment, an increase in the gross profit margin of our Brand Portfolio segment and a higher mix of retail compared to wholesale sales. The decline in the Famous Footwear segment’s gross profit margin was driven by more normalized pricing and an increase in promotional activity. The improvement in the gross profit margin of our Brand Portfolio segment reflects higher average wholesale prices, growth in higher margin sales from the direct-to-consumer channel and a favorable brand mix.

Gross profit increased $71.2 million, or 7.6%, to $1,003.7 million for the nine months ended October 29, 2022, compared to $932.5 million for the nine months ended October 30, 2021, reflecting higher net sales. As a percentage of net sales, gross profit decreased slightly to 44.2% for the nine months ended October 29, 2022, compared to 44.4% for the nine months ended October 30, 2021.

We classify certain warehousing, distribution, sourcing and other inventory procurement costs in selling and administrative expenses. Accordingly, our gross profit and selling and administrative expense rates, as a percentage of net sales, may not be comparable to other companies.

Selling and Administrative Expenses

Selling and administrative expenses increased $29.1 million, or 11.4%, to $283.2 million for the third quarter of 2022, compared to $254.1 million for the third quarter of 2021. The increase was driven by higher salary and benefits expenses, higher expenses associated with our cash-based incentive compensation plans and higher retail facilities costs. As a percentage of net sales, selling and administrative expenses increased to 35.5% for the third quarter of 2022, from 32.4% for the third quarter of 2021, reflecting leveraging of expenses on higher net sales.

Selling and administrative expenses increased $55.3 million, or 7.3%, to $812.3 million for the nine months ended October 29, 2022, compared to $757.0 million for the nine months ended October 30, 2021. The increase primarily reflects higher salary and benefits expenses and higher marketing expenses. As a percentage of net sales, selling and administrative expenses decreased to 35.8% for the nine months ended October 29, 2022, from 36.1% for the nine months ended October 30, 2021, reflecting leveraging of expenses on higher net sales.

Restructuring and Other Special Charges, Net

We incurred restructuring and other special charges of $2.9 million ($2.7 million on an after-tax basis, or $0.07 per diluted share) during the third quarter and nine months ended October 29, 2022, related to a CFO transition at our corporate headquarters. We incurred restructuring and other special charges of $13.5 million ($11.9 million on an after-tax basis, or $0.31 per diluted share) during the nine months ended October 30, 2021, reflecting expenses associated with the strategic realignment of the Naturalizer retail store operations. Refer to Note 5 to the condensed consolidated financial statements for further discussion of these charges.

Operating Earnings

Operating earnings decreased $27.5 million to $53.8 million for the third quarter of 2022, compared to $81.3 million for the third quarter of 2021, primarily reflecting higher selling and administrative expenses and restructuring and other special charges, as described above. As a percentage of net sales, operating earnings were 6.7% for the third quarter of 2022, compared to 10.4% for the third quarter of 2021.

Table of Contents

Operating earnings increased $26.5 million to $188.5 million for the nine months ended October 29, 2022, compared to $162.0 million for the nine months ended October 30, 2021, primarily reflecting higher net sales and gross profit. As a percentage of net sales, operating earnings were 8.3% for the nine months ended October 29, 2022, compared to 7.7% for the nine months ended October 30, 2021.

Interest Expense, Net

Interest expense, net decreased $1.1 million, or 21.0%, to $4.0 million for the third quarter of 2022, compared to $5.1 million for the third quarter of 2021, primarily due to the non-recurrence of the $1.9 million fair value adjustment to the Blowfish Malibu mandatory purchase obligation recorded in the third quarter of 2021, partially offset by higher interest expense on the revolving credit facility. The purchase obligation was settled for $54.6 million on November 4, 2021. In addition, we redeemed our $200 million aggregate principal of senior notes in the second half of 2021. By retiring our senior notes, we shifted debt to our revolving credit agreement, which reduced our interest expense by approximately $1.8 million compared to the third quarter of 2021. These decreases were partially offset by an increase in interest expense under our revolving credit agreement attributable to higher average borrowings and higher interest rates. While the reduction in our total interest expense is expected to continue, the interest on our revolving credit facility is based on a variable interest rate. Therefore, our interest expense will continue to be adversely affected by rising interest rates.

Interest expense, net decreased $19.9 million, or 69.1%, to $8.9 million for the nine months ended October 29, 2022, compared to $28.8 million for the nine months ended October 30, 2021, primarily due to the non-recurrence of the $15.4 million fair value adjustment to the Blowfish Malibu mandatory purchase obligation in the nine months ended October 30, 2021. In addition, after retiring our senior notes, the shift of our higher-rate debt to the lower-rate borrowings under our revolving credit agreement reduced our interest expense by approximately $8.1 million compared to the nine months ended October 30, 2021. These decreases were partially offset by an increase in interest expense our revolving credit agreement attributable to higher average borrowings and higher interest rates.

Loss on Early Extinguishment of Debt

The loss on early extinguishment of debt was $0.6 million for the three and nine months ended October 30, 2021, reflecting the redemption of $100 million of senior notes prior to its maturity and the amendment of our revolving credit facility. Refer to Note 10 to the condensed consolidated financial statements for further discussion. There were no corresponding charges for the nine months ended October 29, 2022.

Other Income, Net

Other income, net decreased $0.8 million, or 22.0%, to $3.0 million for the third quarter of 2022, compared to $3.8 million for the third quarter of 2021, which reflects a reduction of certain components of net periodic benefit income associated with our pension plans.

Other income, net decreased $1.9 million, or 16.4%, to $9.6 million for the nine months ended October 29, 2022, compared to $11.5 million for the nine months ended October 30, 2021, primarily attributable to certain components of net periodic benefit income associated with our pension plans, including interest cost, amortization of actuarial loss and settlement cost. Refer to Note 13 of the condensed consolidated financial statements for further detail regarding the components of net periodic benefit income.

Income Tax Provision

Our effective tax rate can vary considerably from period to period, depending on a number of factors. Our consolidated effective tax rate was 26.2% for the third quarter of 2022, compared to 24.9% for the third quarter of 2021. The higher effective tax rate for the third quarter of 2022 was driven by an increase in permanent adjustments, primarily due to the non-deductible portion of executive compensation.

Our consolidated effective tax rate was 25.7% for the nine months ended October 29, 2022, compared to 27.7% for the nine months ended October 30, 2021. The higher effective tax rate for the nine months ended October 30, 2021 primarily reflects the incremental valuation allowances for our deferred tax assets for certain jurisdictions, as well as the non-deductibility of losses at our Canadian division, which were driven by exit-related costs associated with our Naturalizer retail stores in the first quarter of 2021.

Net Earnings Attributable to Caleres, Inc.

Net earnings attributable to Caleres, Inc. were $39.2 million and $140.9 million for the three and nine months ended October 29, 2022, respectively, compared to net earnings of $59.6 million and $103.2 million for the three and nine months ended October 30, 2021, respectively, as a result of the factors described above.

Table of Contents

FAMOUS FOOTWEAR


	Thirteen Weeks Ended										Thirty-Nine Weeks Ended
	October 29, 2022					October 30, 2021					October 29, 2022					October 30, 2021
				% of					% of					% of					% of
($ millions, except sales per square foot)				Net Sales					Net Sales					Net Sales					Net Sales
Net sales	$	482.0		100.0	%	$	494.7		100.0	%	$	1,302.8		100.0	%	$	1,346.4		100.0	%
Cost of goods sold		266.4		55.3	%		259.2		52.4	%		684.4		52.5	%		703.7		52.3	%
Gross profit		215.6		44.7	%	$	235.5		47.6	%		618.4		47.5	%	$	642.7		47.7	%
Selling and administrative expenses		156.3		32.4	%		148.1		29.9	%		446.9		34.3	%		422.0		31.3	%
Operating earnings	$	59.3		12.3	%	$	87.4		17.7	%	$	171.5		13.2	%	$	220.7		16.4	%

Key Metrics
Same-store sales % change		(0.8)	%				26.5	%				(2.5)	%				11.5	%
Same-store sales $ change	$	(3.7)				$	100.1				$	(32.8)				$	102.7
Sales change from new and closed stores, net	$	(8.5)				$	2.3				$	(9.9)				$	325.1
Impact of changes in Canadian exchange rate on sales	$	(0.5)				$	0.6				$	(0.9)				$	1.7

Sales per square foot, excluding e-commerce (thirteen and thirty-nine weeks ended)	$	72				$	72				$	194				$	194
Sales per square foot, excluding e-commerce (trailing twelve months)	$	250				$	238				$	250				$	238
Square footage (thousand sq. ft.)		5,787					5,977					5,787					5,977

Stores opened		4					1					4					9
Stores closed		9					8					22					20
Ending stores		876					905					876					905

Net Sales

Net sales of $482.0 million in the third quarter of 2022 decreased $12.7 million, or 2.6%, compared to the record setting third quarter of 2021. Despite the decrease in net sales, we continued to perform at a high level during the third quarter of 2022, led by a solid back-to-school season. Although the back-to-school season started slowly in the second quarter, we experienced strong consumer demand in August and September, especially in children’s footwear. We experienced improvement in our non-athletic footwear categories, and while demand slowed for our athletics footwear, it continues to be one of our top-selling categories. Our sales decline was more pronounced in the northern United States due in part to unseasonably warm weather. Same-store sales decreased 0.8% compared to the third quarter of 2021. During the third quarter of 2022, we opened four stores and closed nine stores, resulting in 876 stores and total square footage of 5.8 million at the end of the third quarter of 2022, compared to 905 stores and total square footage of 6.0 million at the end of the third quarter of 2021. Sales to members of our customer loyalty program, Famously You Rewards ("Rewards"), continue to account for a majority of the segment’s sales, with approximately 77% of our net sales made to program members in the third quarter of 2022, compared to 78% in the third quarter of 2021.

Net sales of $1,302.8 million in the nine months ended October 29, 2022 decreased $43.6 million, or 3.2%, compared to the nine months ended October 30, 2021, as our same-store sales declined 2.5%. Athletics and casual continue to be our top-selling categories. We remain focused on maximizing the vertical opportunity between the Famous Footwear and Brand Portfolio segments, with LifeStride and Dr. Scholl’s representing two of Famous Footwear’s top 15 best-selling footwear brands for the nine months ended October 29, 2022.

Gross Profit

Gross profit decreased $19.9 million, or 8.4%, to $215.6 million for the third quarter of 2022, compared to $235.5 million for the third quarter of 2021. As a percentage of net sales, our gross profit decreased to 44.7% for the third quarter of 2022, compared to 47.6% for the third quarter of 2021, reflecting more normalized retail pricing and an increase in promotional activity compared to the third quarter of 2021, when inventories were low due to supply chain constraints. Our gross profit margin continues to exceed pre-pandemic levels.

Gross profit decreased $24.3 million, or 3.8%, to $618.4 million for the nine months ended October 29, 2022, compared to $642.7 million for the nine months ended October 30, 2021, primarily due to the decrease in net sales. As a percentage of net sales, our gross profit decreased slightly to 47.5% for the nine months ended October 29, 2022, compared to 47.7% for the nine months ended October 30, 2021.

Selling and Administrative Expenses

Selling and administrative expenses increased $8.2 million, or 5.6%, to $156.3 million for the third quarter of 2022, compared to $148.1 million for the third quarter of 2021. The increase was driven by higher salary and benefits expenses due in part to wage inflation and higher

Table of Contents

facilities costs. As a percentage of net sales, selling and administrative expenses increased to 32.4% for the third quarter of 2022, compared to 29.9% for the third quarter of 2021.

Selling and administrative expenses increased $24.9 million, or 5.9%, to $446.9 million for the nine months ended October 29, 2022, compared to $422.0 million for the nine months ended October 30, 2021. The increase was primarily due to higher salary and benefits expenses, higher logistics and facilities costs and higher advertising expense. As a percentage of net sales, selling and administrative expenses increased to 34.3% for the nine months ended October 29, 2022, compared to 31.3% for the nine months ended October 30, 2021.

Operating Earnings

Operating earnings decreased $28.1 million to $59.3 million for the third quarter of 2022, compared to $87.4 million for the third quarter of 2021, reflecting both lower sales and gross margins and higher operating expenses, as described above. As a percentage of net sales, operating earnings were 12.3% for the third quarter of 2022, compared to 17.7% for the third quarter of 2021.

Operating earnings decreased $49.2 million to $171.5 million for the nine months ended October 29, 2022, compared to $220.7 million for the nine months ended October 30, 2021, primarily reflecting lower sales and higher operating expenses, as described above. As a percentage of net sales, operating earnings were 13.2% for the nine months ended October 29, 2022, compared to 16.4% for the nine months ended October 30, 2021.

BRAND PORTFOLIO


	Thirteen Weeks Ended										Thirty-Nine Weeks Ended
	October 29, 2022					October 30, 2021					October 29, 2022					October 30, 2021
				% of					% of					% of					% of
($ millions, except sales per square foot)				Net Sales					Net Sales					Net Sales					Net Sales
Net sales	$	323.2		100.0	%	$	300.5		100.0	%	$	1,013.0		100.0	%	$	789.8		100.0	%
Cost of goods sold		200.8		62.1	%		201.6		67.1	%		627.2		61.9	%		502.0		63.6	%
Gross profit		122.4		37.9	%		98.9		32.9	%		385.8		38.1	%		287.8		36.4	%
Selling and administrative expenses		100.1		31.0	%		87.5		29.1	%		292.7		28.9	%		249.2		31.5	%
Restructuring and other special charges, net		—		—	%		—		—	%		—		—	%		13.5		1.7	%
Operating earnings	$	22.3		6.9	%	$	11.4		3.8	%	$	93.1		9.2	%	$	25.1		3.2	%

Key Metrics
Direct-to-consumer (% of net sales) ⁽¹⁾		34	%				28	%				30	%				31	%
Change in wholesale net sales ($)	$	13.0				$	16.5				$	197.2				$	66.2
Unfilled order position at end of period	$	286.8				$	380.7

Same-store sales % change		26.0	%				45.8	%				36.4	%				24.3	%
Same-store sales $ change	$	10.6				$	13.8				$	35.4				$	18.6
Sales change from new and closed stores, net	$	(1.1)				$	2.5				$	(9.7)				$	36.0
Impact of changes in Canadian exchange rate on retail sales	$	0.2				$	0.1				$	0.3				$	0.6

Sales per square foot, excluding e-commerce (thirteen and thirty-nine weeks ended)	$	265				$	236				$	810				$	669
Sales per square foot, excluding e-commerce (trailing twelve months)	$	1,047				$	756				$	1,047				$	756
Square footage (thousands sq. ft.)		104					124					104					124

Stores opened		7					4					11					6
Stores closed		3					1					8					86
Ending stores		89					90					89					90

(1)	Direct-to-consumer includes sales of our retail stores and e-commerce sites and sales through our customers’ websites that we fulfill on a drop-ship basis.

Net Sales

Net sales of $323.2 million in the third quarter of 2022 increased $22.7 million, or 7.6%, compared to the third quarter of 2021, reflecting strong consumer demand for many of our brands. The net sales increase was broad-based across nearly all of our brands, with our Naturalizer, Sam Edelman, Franco Sarto and LifeStride brands being the most significant contributors. In addition to sales increases in our wholesale business, our digital business also experienced significant growth during the quarter. The lead times required on inventory purchases have significantly improved compared to 2021, which has enabled earlier inventory receipts and a more efficient flow of product to our customers.

Table of Contents

During the third quarter of 2022, we opened seven stores and closed three stores, resulting in a total of 89 stores and total square footage of 0.1 million at the end of the third quarter of 2022, compared to 90 stores and total square footage of 0.1 million at the end of the third quarter of 2021.

Net sales increased $223.2 million, or 28.3%, to $1,013.0 million for the nine months ended October 29, 2022, compared to $789.8 million for the nine months ended October 30, 2021, reflecting strong sales growth from nearly all of our brands, with our Sam Edelman, Naturalizer, LifeStride, Franco Sarto and Allen Edmonds brands being the most significant contributors. During 2022, we have experienced a shift in consumer preference from sport and casual products to the fashion and lifestyle categories.

In the first quarter of 2021, we completed the strategic realignment of our Naturalizer retail business and permanently closed the remaining 73 Naturalizer stores in North America that were scheduled for closure. We have continued to focus on growing the brand’s e-commerce business through naturalizer.com, as well as our retail partners and their websites. On a trailing twelve-month basis, sales per square foot, excluding e-commerce sales, increased to $1,047 for the twelve months ended October 29, 2022, compared to $756 for the twelve months ended October 30, 2021. With the closure of nearly all of our Naturalizer retail stores, the majority of the retail stores in our Brand Portfolio segment are for our Allen Edmonds brand, which have higher retail price points than the Naturalizer brand.

Our unfilled order position for our wholesale sales decreased $93.9 million, or 24.7%, to $286.8 million at October 29, 2022, compared to $380.7 million at October 30, 2021. The decrease in our backlog order levels compared to last year primarily reflects more conservative buying by our wholesale customers as they manage their inventory levels in response to consumer sentiment.

Gross Profit

Gross profit increased $23.5 million, or 23.7%, to $122.4 million for the third quarter of 2022, compared to $98.9 million for the third quarter of 2021, primarily reflecting higher net sales and a higher gross margin rate. As a percentage of net sales, our gross profit increased to 37.9% for the third quarter of 2022, compared to 32.9% for the third quarter of 2021, primarily reflecting higher average wholesale prices, growth in higher margin sales from the direct-to-consumer channel and a favorable brand mix, partially offset by a higher provision for inventory markdowns.

Gross profit increased $98.0 million, or 34.1%, to $385.8 million for the nine months ended October 29, 2022, compared to $287.8 million for the nine months ended October 30, 2021, reflecting higher net sales. As a percentage of net sales, our gross profit increased to 38.1% for the nine months ended October 29, 2022, compared to 36.4% for the nine months ended October 30, 2021. While we have experienced inflationary pressures related to product costs and inbound freight through the nine months ended October 29, 2022, we have been able to successfully offset the majority of these impacts through price increases. We anticipate inflationary pressures to continue throughout 2022 and will continue to focus on mitigating the impact.

Selling and Administrative Expenses

Selling and administrative expenses increased $12.6 million, or 14.3%, to $100.1 million for the third quarter of 2022, compared to $87.5 million for the third quarter of 2021. The increase was primarily due to higher variable salary expenses and wage inflation, higher marketing expenses and higher facilities costs. As a percentage of net sales, selling and administrative expenses increased to 31.0% for the third quarter of 2022, compared to 29.1% for the third quarter of 2021.

Selling and administrative expenses increased $43.5 million, or 17.5%, to $292.7 million for the nine months ended October 29, 2022, compared to $249.2 million for the nine months ended October 30, 2021. The increase was driven by higher variable salary expenses and higher marketing expenses. As a percentage of net sales, selling and administrative expenses decreased to 28.9% for the nine months ended October 29, 2022, compared to 31.5% for the nine months ended October 30, 2021, reflecting better leveraging of expenses over a higher net sales base.

Restructuring and Other Special Charges, Net

We incurred restructuring and other special charges of $13.5 million during the nine months ended October 30, 2021 for expenses associated with the strategic realignment of our Naturalizer retail store operations. Refer to Note 5 to the condensed consolidated financial statements for additional information related to these charges. There were no corresponding charges during the three or nine months ended October 29, 2022.

Table of Contents

Operating Earnings

Operating earnings increased to $22.3 million for the third quarter of 2022, from $11.4 million for the third quarter of 2021, as a result of the factors described above. As a percentage of net sales, operating earnings were 6.9% for the third quarter of 2022, compared to 3.8% in the third quarter of 2021.

Operating earnings increased to $93.1 million for the nine months ended October 29, 2022, from $25.1 million for the nine months ended October 30, 2021, as a result of the factors described above. As a percentage of net sales, operating earnings were 9.2% for the nine months ended October 29, 2022, compared to 3.2% in the nine months ended October 30, 2021.

ELIMINATIONS AND OTHER


	Thirteen Weeks Ended								Thirty-Nine Weeks Ended
	October 29, 2022				October 30, 2021				October 29, 2022				October 30, 2021
			% of				% of				% of				% of
($ millions)			Net Sales				Net Sales				Net Sales				Net Sales
Net sales	$	(6.9)	100.0	%	$	(11.0)	100.0	%	$	(44.2)	100.0	%	$	(37.9)	100.0	%
Cost of goods sold		(8.8)	127.6	%		(12.0)	108.8	%		(43.6)	98.7	%		(39.9)	105.3	%
Gross profit		1.9	(27.6)	%		1.0	(8.8)	%		(0.6)	1.3	%		2.0	(5.3)	%
Selling and administrative expenses		26.7	(385.4)	%		18.4	(167.1)	%		72.6	(164.3)	%		85.9	(226.5)	%
Restructuring and other special charges, net		2.9	(42.0)	%		—	—	%		2.9	(6.6)	%		—	—	%
Operating loss	$	(27.7)	399.8	%	$	(17.4)	158.3	%	$	(76.1)	172.2	%	$	(83.9)	221.2	%

The Eliminations and Other category includes the elimination of intersegment sales and profit, unallocated corporate administrative expenses, and other costs and recoveries.

The net sales elimination of $6.9 million for the third quarter of 2022 is $4.1 million, or 37.1%, lower than the third quarter of 2021 reflecting a decrease in product sold from our Brand Portfolio segment to Famous Footwear. The net sales elimination of $44.2 million for the nine months ended October 29, 2022 is $6.3 million, or 16.5%, higher than the nine months ended October 30, 2022 reflecting an increase in product sold from our Brand Portfolio segment to Famous Footwear.

Selling and administrative expenses increased $8.3 million, to $26.7 million in the third quarter of 2022, compared to $18.4 million for the third quarter of 2021. The increase primarily reflects higher expenses for our cash-based incentive compensation plans. In 2021, our financial results exceeded the targets established for our annual incentive plans earlier in the year, which resulted in a larger portion of the anticipated plan payouts recorded as expense in the first half of 2021 rather than in the third quarter. For 2022, anticipated incentive plan payouts are being recognized more ratably during the year.

Selling and administrative expenses decreased $13.3 million, to $72.6 million for the nine months ended October 29, 2022, compared to $85.9 million for the nine months ended October 30, 2021. The decrease primarily reflects lower expenses for our cash-based incentive compensation plans reflecting the shift in timing of the achievement of our financial performance targets, as described above, as well as lower expenses associated with certain other employee benefits.

Restructuring and other special charges of $2.9 million for the three and nine months ended October 29, 2022 were associated with a CFO transition at our corporate headquarters. Refer to Note 5 to the condensed consolidated financial statements for additional information related to these charges. There were no corresponding charges for the nine months ended October 30, 2021.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Borrowings


($ millions)	October 29, 2022		October 30, 2021		⁽¹⁾	January 29, 2022
Borrowings under revolving credit agreement	$	364.5	$	175.0		$	290.0
Current portion of long-term debt		—		99.6			—
Total debt	$	364.5	$	274.6		$	290.0

(1)

As presented here, total debt as of October 30, 2021 excludes the Blowfish Malibu mandatory purchase obligation, which was valued at $54.6 million. The mandatory purchase obligation of $54.6 million was paid on November 4, 2021, as further discussed in Note 14 to the condensed consolidated financial statements.

Total debt obligations of $364.5 million at October 29, 2022 increased $89.9 million, from $274.6 million at October 30, 2021, and increased $74.5 million, from $290.0 million at January 29, 2022. The increase in total debt from October 30, 2021 and January 29, 2022 is due primarily to $63.2 million of repurchases of our common stock. In August 2021, we redeemed $100.0 million aggregate principal amount of our senior notes and on January 3, 2022, we redeemed the remaining $100.0 million of senior notes. We shifted this debt to borrowings under the revolving credit facility, which has resulted in significant interest expense savings for the Company. While this reduction in interest expense is expected to continue, the interest on our revolving credit facility is based on a variable interest rate, which has resulted in higher interest expense in the current rising interest rate environment. Our interest expense will continue to be adversely affected by rising interest rates. Net interest expense for the third quarter of 2022 decreased $1.1 million to $4.0 million, compared to $5.1 million for the third quarter of 2021. The decrease is primarily attributable to the non-recurrence of the $1.9 million fair value adjustment to the Blowfish Malibu mandatory purchase obligation recorded in the third quarter of 2021. The Blowfish Malibu mandatory purchase obligation of $54.6 million was paid on November 4, 2021, as further discussed in Note 5 and Note 14 to the condensed consolidated financial statements. In addition, as discussed above, the redemption of all outstanding senior notes in 2021 also contributed to the decrease in interest expense in the third quarter of 2022. These decreases were partially offset by higher average borrowings under our revolving credit agreement.

Credit Agreement

As further discussed in Note 10 to the condensed consolidated financial statements, the Company maintains a revolving credit facility for working capital needs. On October 5, 2021, we entered into a Fifth Amendment to Fourth Amended and Restated Credit Agreement (as so amended, the “Credit Agreement”) which, among other modifications, extended the maturity date of the credit facility from January 18, 2024, to October 5, 2026 and decreased the amount available under the revolving credit facility by $100.0 million to an aggregate amount of up to $500.0 million, subject to borrowing base restrictions, and may be increased by up to $250.0 million. Interest on the borrowings is at variable rates based on the London Interbank Offered Rate ("LIBOR") (with a floor of 0.0%), or the prime rate (as defined in the Credit Agreement), plus a spread. The Credit Agreement decreased the spread applied to the LIBOR or prime rate by a total of 75 basis points. At October 29, 2022, we had $364.5 million in borrowings and $10.1 million in letters of credit outstanding under the Credit Agreement. Total borrowing availability was $125.4 million at October 29, 2022. We were in compliance with all covenants and restrictions under the Credit Agreement as of October 29, 2022.

Senior Notes

On July 27, 2015, we issued $200.0 million aggregate principal amount of senior notes due in 2023 (the "Senior Notes"). The Senior Notes were guaranteed on a senior unsecured basis by each of the subsidiaries of Caleres, Inc. that is an obligor under the Credit Agreement, and bore interest of 6.25%, which was payable on February 15 and August 15 of each year. On August 16, 2021, we redeemed $100.0 million of the Senior Notes at 100.0%. In addition, on January 3, 2022, we redeemed the remaining $100.0 million of Senior Notes at 100.0%. Refer to further discussion regarding the Senior Notes in Note 10 to the condensed consolidated financial statements.

Table of Contents

Working Capital and Cash Flow


	Thirty-Nine Weeks Ended
($ millions)	October 29, 2022		October 30, 2021		Change
Net cash provided by operating activities	$	46.3	$	189.7	$	(143.4)
Net cash used for investing activities		(45.4)		(14.6)		(30.8)
Net cash provided by (used for) financing activities		1.9		(188.6)		190.5
Effect of exchange rate changes on cash and cash equivalents		(0.1)		(0.0)		(0.1)
Increase (decrease) in cash and cash equivalents	$	2.7	$	(13.5)	$	16.2

Reasons for the major variances in cash provided (used) in the table above are as follows:

Cash provided by operating activities was $143.4 million lower in the nine months ended October 29, 2022 as compared to the nine months ended October 30, 2021, primarily reflecting the following factors:

●

A decrease in trade accounts payable during the nine months ended October 29, 2022, compared to an increase during the nine months ended October 30, 2021, due in part to the earlier receipt of fall product in 2022 and the earlier settlement of the related accounts payable;

●

A decrease in accrued expenses and other liabilities during the nine months ended October 29, 2022, compared to an increase during the nine months ended October 30, 2021 due in part to higher accruals for incentive compensation payments in 2021, reflecting operating results that exceeded the targets established for the annual incentive plan; partially offset by

●

Higher net earnings in the nine months ended October 29, 2022, compared to the nine months ended October 30, 2021.

Supply chain financing: Certain of our suppliers are given the opportunity to sell receivables from us related to products that we have purchased to participating financial institutions at a rate that leverages our credit rating, which may be more beneficial to the suppliers than the rate they can obtain based upon their own credit rating. We negotiate payment and other terms with our suppliers, regardless of whether the supplier participates in the program, and our responsibility is limited to making payment based on the terms originally negotiated with the supplier. These liabilities continue to be presented as accounts payable in our condensed consolidated balance sheets, with changes reflected within cash flows from operating activities when settled. As of October 29, 2022 and October 30, 2021, we had $17.8 million and $64.0 million, respectively, of accounts payable subject to supply chain financing arrangements.

Cash used for investing activities was $30.8 million higher for the nine months ended October 29, 2022 as compared to the nine months ended October 30, 2021, reflecting higher capital expenditures. In 2022, we expect our purchases of property and equipment and capitalized software to be between $50 million and $60 million, as compared to $24.1 million in 2021. In the first quarter of 2022, we tested a new prototype Famous Footwear store that offers an enhanced shopping experience, highlights our leading assortment of trending brands and elevates those brands in an energetic and exciting manner. We have also continued to invest in refreshing our Famous Footwear stores in the first nine months of 2022. We have experienced strong financial performance from the recently converted prototype stores. Accordingly, we plan to invest in additional prototype stores and store renovations during the fourth quarter of 2022 and into 2023, which we believe will enhance our brand image and further differentiate our store experience from that of our competitors.

Cash provided by financing activities was $190.5 million higher for the nine months ended October 29, 2022 as compared to the nine months ended October 30, 2021, primarily due to net borrowings on our revolving credit agreement of $74.5 in the nine months ended October 29, 2022, compared to net repayments of $75.0 million in the comparable period in 2021. In addition, we repurchased $63.2 million of our common stock under our share repurchase programs during the nine months ended October 29, 2022, with no corresponding share repurchases during the nine months ended October 30, 2021.

Table of Contents

A summary of key financial data and ratios at the dates indicated is as follows:


	October 29, 2022			October 30, 2021			January 29, 2022
Working capital ($ millions) ⁽¹⁾	$	(117.8)		$	(207.4)		$	(189.1)
Current ratio ⁽²⁾		0.89:1			0.81:1			0.82:1
Debt-to-capital ratio⁽³⁾		47.3	%		47.3	%		47.3	%

(1)	Working capital has been computed as total current assets less total current liabilities.

(2)	The current ratio has been computed by dividing total current assets by total current liabilities.

(3)	The debt-to-capital ratio has been computed by dividing total debt by total capitalization. Total debt is defined as the current portion of long-term debt and borrowings under revolving credit agreement. Total capitalization is defined as total debt and total equity.

Working capital at October 29, 2022 was ($117.8) million, which was $89.6 million and $71.3 million higher than at October 30, 2021 and January 29, 2022, respectively. The increase in working capital from October 30, 2021 primarily reflects higher inventory, the redemption of our senior notes, lower trade accounts payable and the settlement of the Blowfish Malibu mandatory purchase obligation in the fourth quarter of 2021, partially offset by higher borrowings under the revolving credit agreement. The increase in working capital from January 29, 2022 primarily reflects higher inventories and accounts receivable and lower trade accounts payable, partially offset by higher borrowings under the revolving credit agreement. Our current ratio was 0.89 to 1 as of October 29, 2022, compared to 0.81:1 at October 30, 2021 and 0.82:1 at January 29, 2022. Our debt-to-capital ratio was 47.3% as of October 29, 2022, consistent with October 30, 2021 and January 29, 2022.

We declared and paid dividends of $0.07 per share in the third quarter of both 2022 and 2021. The declaration and payment of any future dividend is at the discretion of the Board of Directors and will depend on our results of operations, financial condition, business conditions and other factors deemed relevant by our Board of Directors. However, we presently expect that dividends will continue to be paid.

We have various contractual or other obligations, including borrowings under our revolving credit facility, operating lease commitments, one-time transition tax for the mandatory deemed repatriation of cumulative foreign earnings and obligations for our supplemental executive retirement plan and other postretirement benefits. We also have purchase obligations to purchase inventory, assets and other goods and services. We believe our operating cash flows are sufficient to meet our material cash requirements for at least the next 12 months.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

No material changes have occurred related to critical accounting policies and estimates since the end of the most recent fiscal year. For further information on the Company’s critical accounting policies and estimates, see Part II, Item 7 of our Annual Report on Form 10-K for the year ended January 29, 2022.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Recently issued accounting pronouncements, if any, and their impact on the Company are described in Note 2 to the condensed consolidated financial statements.

FORWARD-LOOKING STATEMENTS

This Form 10-Q contains certain forward-looking statements and expectations regarding the Company’s future performance and the performance of its brands. Such statements are subject to various risks and uncertainties that could cause actual results to differ materially. These risks include (i) supply chain disruptions and inflationary pressures; (ii) the coronavirus pandemic and its adverse impact on our business operations and financial condition; (iii) changing consumer demands, which may be influenced by general economic conditions and other factors; (iv) rapidly changing consumer preferences and purchasing patterns and fashion trends; (v) customer concentration and increased consolidation in the retail industry; (vi) intense competition within the footwear industry; (vii) foreign currency fluctuations; (viii) political and economic conditions or other threats to the continued and uninterrupted flow of inventory from China and other countries, where the Company relies heavily on third-party manufacturing facilities for a significant amount of its inventory; (ix) cybersecurity threats or other major disruption to the Company’s information technology systems; (x) the ability to accurately forecast sales and manage inventory levels; (xi) a disruption in the Company’s distribution centers; (xii) the ability to recruit and retain senior management and other key associates; (xiii) the ability to secure/exit leases on favorable terms; (xiv) the ability to maintain relationships with current suppliers; (xv)

Table of Contents

transitional challenges with acquisitions and divestitures; (xvi) changes to tax laws, policies and treaties; (xvii) compliance with applicable laws and standards with respect to labor, trade and product safety issues; and (xviii) the ability to attract, retain, and maintain good relationships with licensors and protect our intellectual property rights. The Company’s reports to the Securities and Exchange Commission contain detailed information relating to such factors, including, without limitation, the information under the caption “Risk Factors” in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended January 29, 2022, which information is incorporated by reference herein and updated by the Company’s Quarterly Reports on Form 10-Q. The Company does not undertake any obligation or plan to update these forward-looking statements, even though its situation may change.

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

No material changes have taken place in the quantitative and qualitative information about market risk since the end of the most recent fiscal year. For further information, see Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended January 29, 2022.

ITEM 4 CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

It is the Chief Executive Officer’s and Chief Financial Officer’s ultimate responsibility to ensure we maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures include mandatory communication of material events, automated accounting processing and reporting, management review of monthly, quarterly and annual results, an established system of internal controls and ongoing monitoring by our internal auditors.

A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Furthermore, the design of a control system must reflect the fact there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to errors or fraud may occur and not be detected. Our disclosure controls and procedures are designed to provide a reasonable level of assurance that their objectives are achieved. As of October 29, 2022, management of the Company, including the Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon and as of the date of that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded our disclosure controls and procedures were effective at the reasonable assurance level.

Based on the evaluation of internal control over financial reporting, the Chief Executive Officer and Chief Financial Officer have concluded that there have been no changes in the Company’s internal controls over financial reporting during the quarter ended October 29, 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1 LEGAL PROCEEDINGS

We are involved in legal proceedings and litigation arising in the ordinary course of business. In the opinion of management, the outcome of such ordinary course of business proceedings and litigation currently pending will not have a material adverse effect on our results of operations or financial position. All legal costs associated with litigation are expensed as incurred.

Table of Contents

Information regarding Legal Proceedings is set forth within Note 16 to the condensed consolidated financial statements and incorporated by reference herein.

ITEM 1A RISK FACTORS

There have been no material changes that have occurred related to our risk factors since the end of the most recent fiscal year. For further information, see Part I, Item 1A of our Annual Report on Form 10-K for the year ended January 29, 2022.

ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information relating to our repurchases of common stock during the third quarter of 2022:


				Total Number	Maximum Number
				Purchased as Part	of Shares that May
	Total Number of			of Publicly	Yet be Purchased
	Shares	Average Price Paid		Announced	Under the
Fiscal Period	Purchased⁽¹⁾		per Share ⁽¹⁾	Program ⁽²⁾	Program ⁽²⁾
July 31, 2022 - August 27, 2022	—	$	—	—	7,205,404

August 28, 2022 - October 1, 2022	844,433		25.71	838,025	6,367,379

October 2, 2022 - October 29, 2022	32,443		25.70	—	6,367,379
Total	876,876	$	25.71	838,025	6,367,379

(1)

Includes shares purchased as part of our publicly announced stock repurchase programs and shares that were tendered by employees related to certain share-based awards. The employee shares were tendered in satisfaction of the exercise price of stock options and/or to satisfy tax withholding amounts for non-qualified stock options, restricted stock and stock performance awards.

(2)

On September 2, 2019, the Board of Directors approved a stock repurchase program ("2019 Program") authorizing the repurchase of 5,000,000 shares of our outstanding common stock. In addition, on March 10, 2022, the Board of Directors approved a stock repurchase program ("2022 Program") authorizing the repurchase of an additional 7,000,000 shares of our outstanding common stock. We can use the repurchase programs to repurchase shares on the open market or in private transactions from time to time, depending on market conditions. The repurchase programs do not have an expiration date. During the thirteen and thirty-nine weeks ended October 29, 2022, the Company repurchased 838,025 and 2,622,845 shares, respectively, under these programs. The Company did not repurchase any shares under these programs during the thirty-nine weeks ended October 30, 2021. As of October 29, 2022, there were 6,367,379 shares authorized to be repurchased under the repurchase programs. Our repurchases of common stock are limited under our revolving credit agreement.

ITEM 3 DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4 MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5 OTHER INFORMATION

None.

Table of Contents

ITEM 6 EXHIBITS


Exhibit No.
3.1		Restated Certificate of Incorporation of Caleres, Inc. (the “Company”) incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed May 29, 2020.
3.2		Bylaws of the Company as amended through May 26, 2022, incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed May 27, 2022.
10.10*	†	Severance Agreement, effective September 12, 2022, between the Company and Jack P. Calandra, filed herewith.
31.1	†	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	†	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	†	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	†	iXBRL Instance Document
101.SCH	†	iXBRL Taxonomy Extension Schema Document
101.CAL	†	iXBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	†	iXBRL Taxonomy Extension Label Linkbase Document
101.PRE	†	iXBRL Taxonomy Presentation Linkbase Document
101.DEF	†	iXBRL Taxonomy Definition Linkbase Document
104	†	Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.

* Denotes management contract or compensatory plan arrangements.

† Denotes exhibit is filed with this Form 10-Q.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CALERES, INC.

Date: December 6, 2022		/s/ Jack P. Calandra
		Jack P. Calandra Senior Vice President and Chief Financial Officer on behalf of the Registrant and as the Principal Financial Officer

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

Caleres (CAL) 10-Q2022 Q3 Quarterly report

Content analysis